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SUMMARY 
 
 Excess salt intake increases blood pressure particularly during states of 
hyperinsulinism and insulin resistance. Insulin is presumably effective through activation of 
ENaC. Excess salt intake further decreases peripheral glucose uptake thus impairing glucose 
tolerance. Stimulation of both, the epithelial Na+ channel ENaC and of cellular glucose 
uptake involves phosphatidylinositide 3-kinase (PI-3K) which signals through protein 
kinase B (Akt/PKB) and all three members of the serum and glucocorticoid inducible kinase 
(SGK) family of kinases SGK1, SGK2 and SGK3. All three kinases have been previously 
shown to modify a variety of transporters including ENaC and the glucose transporter 
SGLT1. To explore the role of SGK1 in salt sensitive hypertension and peripheral glucose 
uptake, experiments were performed in male or female SGK1 knockout mice (sgk1-/-) and their 
wild type littermates (sgk1+/+) which were subjected to standard diet, high-fat diet, high fructose 
diet or dexamethasone treatment and allowed free access to either tap water (control-salt) or 1% 
saline (high-salt).  
 Under control diet fluid intake, blood pressure, urinary flow rate and urinary Na+, K+, Cl- 
excretion were similar in sgk1-/- and sgk1+/+mice, plasma aldosterone concentration was however 
significantly higher in sgk1-/- (1.22 ± 0.18 ng/ml)  than in sgk1+/+mice (0.57 ± 0.11 ng/ml). Under 
standard diet, high-salt-intake (1% NaCl in drinking water for 25 days) increased fluid intake, 
urinary flow rate and urinary Na+, K+, Cl- excretion similarly in sgk1-/- and sgk1+/+mice without 
significantly altering blood pressure. High-fat-diet alone (17 weeks) did not significantly alter 
fluid intake, urinary flow rate, urinary Na+, K+, Cl- excretion or plasma aldosterone levels, but 
increased plasma insulin, total cholesterol and triglyceride concentrations as well as systolic blood 
pressure to the same extent in both genotypes. Additional high-salt-intake (1% NaCl in drinking 
water for 25 days) on top of high-fat-diet did not affect hyperinsulinemia nor hyperlipidemia but 
increased fluid intake, urinary flow rate and urinary NaCl excretion significantly more in sgk1-/- 
than in sgk1+/+mice. Furthermore, in animals receiving high fat diet, additional salt intake 
increased blood pressure only in sgk1+/+mice (132 ± 3 mmHg) but not in sgk1-/-mice (120 ± 4 
mmHg). Renal SGK1 protein abundance of sgk1+/+ mice was significantly elevated 
following high fat diet. 
 During control diet, fluid intake, urinary flow rate, urinary Na+, K+ and Cl- excretion and 
blood pressure were similar in sgk1-/- and sgk1+/+ mice. Addition of 10 % fructose to drinking 
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water increased fluid intake and urinary flow rate in both genotypes and did not significantly alter 
urinary Na+, K+ and Cl- output in neither genotype. Additional high NaCl diet (4 % NaCl) did not 
significantly alter fluid intake and urine volume but markedly increased urinary output of Na+ and 
Cl-, approaching values significantly (p < 0.05) larger in sgk1-/- than in sgk1+/+ mice. Blood 
pressure was similar in sgk1+/+ and sgk1-/- mice at control diet or fructose alone but increased only 
in sgk1+/+ mice (115 ± 1 vs. 103 ± 0.7 mmHg, p < 0.05) following combined fructose and high 
salt intake. Renal SGK1 transcript levels of sgk1+/+ mice were significantly elevated following 
fructose diet. Acute intravenous insulin infusion (during glucose clamp) caused antinatriuresis in 
sgk1+/+ mice, an effect significantly blunted in sgk1-/- mice. The observations reveal a pivotal role 
of SGK1 in insulin mediated sodium retention and the salt sensitizing hypertensive effect of high 
fructose intake. 
 Prior to dexamethasone treatment, the fluid intake, urinary flow rate, urinary Na+, K+ and 
Cl- excretion, plasma electrolyte and glucose concentrations as well as blood pressure were 
similar in sgk1-/- and sgk1+/+ mice. Dexamethasone treatment (3mg/kg, b.w. i.p. for 14 days) did 
not significantly alter renal Na+, K+ and Cl- excretion, but it tended to decrease renal Ca2+ 
excretion in sgk1+/+ mice but significantly increased renal Ca2+ excretion in sgk1-/- mice and 
significantly decreased renal phosphate excretion in sgk1+/+ mice. Dexamethasone treatment 
significantly increased fasting blood glucose concentrations in both genotypes. Dexamethasone 
treatment significantly increased blood pressure in sgk1+/+ mice, an effect significantly blunted in 
sgk1-/- mice. The subsequent replacement of the tap drinking water with saline increased the fluid 
intake, urinary flow rate and urinary NaCl excretion in both genotypes but increased plasma K+ 
concentration only in sgk1-/- mice. Saline loading increased blood pressure in both, sgk1-/- and 
sgk1+/+ mice and dissipated the difference between genotypes. 
 Intraperitoneal injection of glucose (3g/kg/body-weight) into sgk1+/+ mice transiently 
increased plasma glucose concentration approaching significantly higher values 
([glucose]p,max) in high-salt (281 ± 39 mg/dl) than in control animals (164 ± 23 mg/dl). 
DOCA did not significantly modify [glucose]p,max in control sgk1+/+ mice but significantly 
decreased [glucose]p,max in high-salt sgk1+/+ mice, an effect reversed by spironolactone (50 
mg/kg/body-weight). [glucose]p,max was in sgk1-/-mice insensitive to high-salt and 
significantly higher than in control sgk1+/+mice. Uptake of 3H-deoxy-glucose into skeletal 
muscle and fat tissue was significantly smaller in sgk1-/- mice than in sgk1+/+ mice and 
decreased by high-salt in sgk1+/+ mice. According to Western blotting, high-salt decreased and 
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DOCA (35 mg/kg/body-weight) increased SGK1 protein abundance in skeletal muscle and fat 
tissue of sgk1+/+ mice. Transfection of HEK293 cells with active S422DSGK1 but not inactive 
K127NSGK stimulated phloretin-sensitive glucose uptake. 
 In conclusion, lack of SGK1 protects against the hypertensive effects of combined high-
fat-diet/high-salt-intake or high fructose/high salt diet and mediates the salt sensitive peripheral 
glucose uptake. The present observations provide insight into prerequisites for the SGK1 
dependent increase of blood pressure and thus may provide a clue to the increased blood 
pressure in those 5% of the common population carrying the SGK1 gene variant. The 
observations suggest that SGK1 plays a critical role in the hypertensive effect of 
hyperinsulinism. As a gain of function gene variant of SGK1 could simultaneously increase 
blood pressure and body mass index, SGK1 may indeed be one of the signalling molecules 
contributing to metabolic syndrome or syndrome X, a condition characterized by the 
coincidence of several disorders including hypertension, obesity, insulin resistance and 
hyperinsulinemia. Metabolic syndrome shares several attributes of Cushing´s syndrome, but 
does not require increased plasma cortisol levels. Instead, the disorder may be caused by 
inappropriate activity of downstream signaling elements which could well include the 
serum and glucocorticoid inducible kinase SGK1. 
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Zusammenfassung 
 
Exzessive Salzaufnahme erhöht den Blutdruck, besonders unter Hyperinsulinämie 
und Insulinresistenz. Insulin wirkt vermutlich über Aktivierung des epithelialen 
Natriumskanals ENaC. Weiterhin vermindert exzessive Salzaufnahme die periphere 
Glucoseaufnahme und beeinträchtigt somit die Glucosetoleranz. Bei der Stimulation des 
epithelialen Natriumkanals ENaC als auch der zellulären Glucoseaufnahme ist die 
Phosphatidylinositol-3-kinase (PI-3K) beteiligt, deren Signalkaskade die Proteinkinase B 
(Akt/PKB) und alle drei Mitglieder der Serum- und Glukokortikoid-induzierbaren Kinase 
(SGK)-Familie SGK1, SGK2 und SGK3 einschließt. Für alle drei Kinasen wurde kürzlich 
gezeigt, dass sie eine Vielzahl von Transportern regulieren, darunter ENaC und den 
Glucosetransporter SGLT1. Um die Rolle von SGK1 bei salzabhängiger Hypertonie und 
peripherer Glucoseaufnahme zu untersuchen, wurden Experimente in SGK1-Knockout-
Mäusen (sgk1-/-) und den Wildtyp-Geschwistern (sgk1+/+) durchgeführt, die einer Standard-
Diät, einer fettreichen Diät, einer hohen Fructose-Diät und Dexamethasonbehandlung 
unterzogen wurden und die freien Zugang entweder zu Leitungswasser (Kontrolle) oder zu 
1%iger NaCl-Lösung (hohe Salzzufuhr) hatten. 
Unter Kontrollbedingungen waren Flüssigkeitsaufnahme, Blutdruck, Harnflussrate 
und Ausscheidung von Na+, K+ und Cl- mit dem Urin bei sgk1-/-- und sgk1+/+-Mäusen ähnlich, 
die Plasma-Aldosteron-Konzentration war jedoch bei sgk1-/--Mäusen (1.22 ± 0.18 ng/ml) 
signifikant höher als bei sgk1+/+-Mäusen (0.57 ± 0.11 ng/ml). Unter Standarddiät erhöhte eine 
hohe Salzzufuhr (1% NaCl im Trinkwasser für 25 Tage) Flüssigkeitsaufnahme, Harnflussrate 
und Urin-Ausscheidung von Na+, K+ und Cl- bei sgk1-/-- und sgk1+/+-Mäusen in ähnlicher Weise 
ohne den Blutdruck signifikant zu ändern. Eine alleinige fettreiche Diät über 17 Wochen änderte 
Flüssigkeitsaufnahme, Harnflussrate, Urin-Ausscheidung von Na+, K+ und Cl- oder die Plasma-
Aldosteron-Spiegel nicht signifikant, aber erhöhte bei beiden Genotypen die Plasmainsulinspiegel 
im gleichen Ausmaß, die Plasmakonzentrationen von Gesamtcholesterin und Triglyceriden 
ebenso wie den systolischen Blutdruck. Eine zur fettreichen Diät zusätzlich verabreichte 
Salzzufuhr (1% NaCl im Trinkwasser für 25 Tage) beeinflusste weder Hyperinsulinämie noch 
Hyperlipidämie, aber Flüssigkeitsaufnahme, Harnflussrate und Urin-Ausscheidung von Na+ und 
Cl-. Letztere waren bei sgk1-/--Mäusen im Vergleich zu sgk1+/+-Mäusen signifikant erhöht. Diese 
Behandlung erhöhte nur bei sgk1+/+-Mäusen den Blutdruck (132 ± 3 mmHg) nicht jedoch bei 
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sgk1-/--Mäusen (120 ± 4 mmHg). Die Proteinexpression der SGK1 in der Niere war bei 
sgk1+/+-Mäusen nach einer fettreichen Diät signifikant erhöht. 
Ein Zusatz von 10% Fructose zum Trinkwasser erhöhte Flüssigkeitsaufnahme und 
Harnflussrate bei beiden Genotypen und änderte die Urin-Ausscheidung von Na+, K+ and Cl- 
nicht. Eine zusätzliche Salzbelastung in Form einer NaCl-reichen Diät (4% NaCl) änderte 
Flüssigkeitsaufnahme und Harnvolumen nicht signifikant, aber erhöhte deutlich die Urin-
Ausscheidung von Na+ und Cl- und erreichte bei sgk1-/--Mäusen signifikant höhere Werte als bei 
sgk1+/+-Mäusen. Der Blutdruck war bei sgk1+/+- und sgk1-/--Mäusen unter Kontrolldiät oder 
alleiniger Fructosezugabe ähnlich und war nur bei sgk1+/+-Mäusen (115 ± 1 vs. 103 ± 1 mmHg) 
unter einer kombinierten Fructose- und hohen Salzaufnahme erhöht. Eine akute intravenöse 
Insulininfusion unter gleichzeitiger Glucoseinfusion bewirkte in sgk1+/+-Mäusen eine 
Antinatriurese. Dieser Effekt war bei sgk1-/--Mäusen signifikant abgeschwächt. Die 
Beobachtungen zeigten, dass SGK1 bei Insulin-vermittelter Natriumretention und bei 
salzabhängigen hypertensiven Effekten durch hohe Fructoseaufnahme eine zentrale Rolle spielt. 
Vor Behandlung mit Dexamethason waren Flüssigkeitsaufnahme, Harnflussrate, Urin-
Ausscheidung von Na+, K+ and Cl-, Plasmaelektrolyt- und Glucosekonzentrationen ebenso wie 
Blutdruck bei sgk1-/-- und sgk1+/+-Mäusen ähnlich. Behandlung mit Dexamethason (3mg/kg 
Körpergewicht, i.p. für 14 Tage) veränderte die renale Na+-, K+- und Cl--Ausscheidung nicht 
signifikant, aber verringerte die renale Ca2+-Ausscheidung bei sgk1+/+-Mäusen tendenziell, bei 
sgk1-/--Mäusen kam es allerdings zu einer signifikanten Erhöhung der renalen Ca2+-Ausscheidung. 
Die Dexamethason-Behandlung erhöhte die Blutglucosekonzentration nach Fasten bei beiden 
Genotypen signifikant. Darüberhinaus, erhöhte die Dexamethason-Behandlung den Blutdruck bei 
sgk1+/+-Mäusen signifikant, dieser Effekt war bei sgk1-/--Mäusen signifikant abgeschwächt. Im 
folgenden wurde das Trinkwasser mit Salz versetzt, was Flüssigkeitsaufnahme, Harnflussrate und 
NaCl-Ausscheidung im Urin bei beiden Genotypen erhöhte, die Plasma-K+-Konzentration jedoch 
nur bei sgk1-/--Mäusen erhöhte. Die Salzlast erhöhte den Blutdruck sowohl bei sgk1-/-- als auch bei 
sgk1+/+-Mäusen und es gab keinen Unterschied zwischen beiden Genotypen. 
Während eines intraperitonealen Glucosetoleranztests (3g/kg/Körpergewicht) in sgk1+/+-
Mäusen stieg die Plasmaglucosekonzentration vorübergehend an und erreichte dabei bei Mäusen 
unter NaCl-reichen Diät (281 ± 39 mg/dl) signifikant höhere Spitzenwerte als bei den 
Kontrolltieren (164 ± 23 mg/dl). DOCA (35 mg/kg/KG) alleine veränderte in der 
Kontrollgruppe der sgk1+/+-Mäuse die Spitzenwerte nicht signifikant, aber verminderte diese 
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signifikant unter gleichzeitiger NaCl-reichen Diät. Dieser Effekt konnte durch Spironolacton (50 
mg/kg/KG) umgekehrt werden. Die Spitzenwerte waren bei sgk1-/--Mäusen unabhängig von 
hoher Salzdiät signifikant höher als in der Kontrollgruppe der sgk1+/+-Mäuse. Die 
Aufnahme von 3H-desoxy-glucose in den Skelettmuskel und ins Fettgewebe war bei sgk1-/--
Mäusen signifikant geringer als bei sgk1+/+-Mäusen und bei sgk1+/+-Mäusen durch eine hohe 
Salzdiät verringert. Im Western-Blot verminderte eine hohe Salzzufuhr die Proteinexpression der 
SGK1 im Skelettmuskel und im Fettgewebe von sgk1+/+-Mäusen, DOCA erhöhte diese. Die 
Transfektion von HEK293-Zellen mit aktivem S422DSGK1, aber nicht inaktivem K127NSGK 
stimulierte die Phloretin-abhängige Glucoseaufnahme. 
Schlussfolgernd kann man sagen, dass ein Mangel an SGK1 vor hypertensiven Effekten 
unter kombinierter hoher Fettdiät und hoher Salzzufuhr oder unter hoher Fructosezufuhr und 
hoher Salzdiät schützt und die salzabhängige periphere Glucoseaufnahme moduliert. Die 
aktuellen Beobachtungen ergeben Hinweise für die SGK1-abhängige Steigerung des Blutdrucks 
und stellen damit möglicherweise einen Erklärungsansatz für den erhöhten Blutdruck bei jenen 
5% der Gesamtbevölkerung mit einem SGK1-Genpolymorphismus dar. Die Beobachtungen 
lassen vermuten, dass die SGK1 eine entscheidende Rolle im Hinblick auf hypertensive Effekte 
unter Hyperinsulinämie spielt. Da eine Überfunktion der SGK1-Genvariante gleichzeitig den 
Blutdruck und den Körpermassenindex BMI erhöhen könnte, ist SGK1 vermutlich in der Tat 
eines der Signalmoleküle, das zum metabolischen Syndrom oder Syndrom X führt, ein Zustand, 
der durch das Zusammenwirken mehrerer Funktionsstörungen charakterisiert ist, darunter 
Bluthochdruck, Übergewicht, Insulinresistenz  und Hyperinsulinämie. Das metabolische 
Syndrom hat einige Merkmale mit dem Cushing-Syndrom gemeinsam, aber weist keinen 
erhöhten Plasma-Cortisolspiegel auf. Stattdessen wird die Störung vermutlich von unangemessen 
erhöhter Aktivität von “downstream”-Signalelementen verursacht, die durchaus die Serum- und 
Glukokortikoid-induzierbare Kinase SGK1 miteinschließen könnte.  
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I. INTRODUCTION 
 
Serum and glucocorticoid inducible kinase (SGK1) was originally isolated in a 
differential screen searching for glucocorticoid-induced transcripts in a mammary tumor 
cell line (Webster et al., 1993). It was found to be induced within 30 minutes, either  by 
glucocorticoids or serum and in both mammary epithelial cells and fibroblasts (Webster et 
al., 1993; Webster et al., 1993a). This induction persisted in mammary cells (Webster et al., 
1993), whereas in fibroblasts it was transient and returned to normal after 4 hours of 
induction. Sgk mRNA is extremely unstable in fibroblasts (Webster et al., 1993a), a finding 
that subsequently has been confirmed in other cells (Kumar et al., 1999). SGK (specifically 
SGK1, as there are two closely related paralogs referred to as SGK2 and SGK3) is 
remarkable in that it is tightly regulated by numerous signaling molecules via its expression 
levels, intrinsic kinase activity and subcellular localization. These properties allow it to 
integrate numerous signaling pathways. It is best known as a kinase that acts as a cell 
survival molecule in different situations and that is able to regulate numerous membrane 
transport and channel proteins.  
SGK1 is a member of the AGC family of serine/ threonine protein kinases. Its 
catalytic domain is approximately 45–60% homologous to the catalytic domains of other  
serine/threonine protein kinases such as Akt/protein kinase B or protein kinase A (PKA) 
(Webster et al., 1993). In accordance with its name, the expression of SGK1 in the kidney is 
sensitive to glucocorticoids (Alvarez de la Rosa et al., 2003; Brennan et al., 2000; Shigaev 
et al., 2000). Based on studies in rat kidney, Alvarez de la Rosa et al. (2003) suggested that 
approximately half of the basal level of renal SGK1 expression is maintained by 
glucocorticoids. Moreover, aldosterone upregulates the expression of SGK1 in the ASDN 
(Firestone et al., 2003; Pearce 2003; Verrey et al., 2003; Vallon et al., 2005; Bhargava et al., 
2004). Whereas aldosterone can stimulate the expression of SGK1, the latter has to be 
phosphorylated for activation. Phosphorylation of SGK1 involves signaling cascades that 
include phosphatidylinositol 3-kinase and the 3-phospho- inositide-dependent kinases 
PDK1 and PDK2 (Biondi et al., 2001; Kobayashi et al., 1999; Park et al., 1999; Tong et al., 
2004). Reported 3-phosphoinositide-dependent kinase-dependent activators of SGK1 
include insulin and growth factors such as insulin-like growth factor (Kobayashi et al., 
1999; Hayashi et al., 2001; Perrotti et al., 2001). Further, aldosterone itself may promote 
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SGK1 activation by a phosphatidylinositol 3-kinase-dependent mechanism (Tong et al., 
2004; Blazer Yost et al., 1999; Wang et al., 2001). Other pathways independent of 
phosphatidylinositol (3,4,5)-trisphosphate such as cell–cell and matrix interactions and  
phosphorylation by PKA have also been found to activate SGK1 (Perrotti et al., 2001; 
Shelly et al., 2002). Thus, SGK1 may integrate the influences of aldosterone and factors like 
insulin or PKA-activator arginine vasopressin on renal NaCl reabsorption (Wang et al., 
2001; Faletti et al., 2002). 
SGK1 is induced by a very large spectrum of stimuli distinct from glucocorticoids 
and serum (Table 1). These include aldosterone (Chen et al., 1999; Naray-Feges-Toth et al., 
1999), cell shrinkage (Waldegger et al., 1997; Warntges et al., 2002), cell swelling 
(Rozansky et al., 2002), TGF-β (Waldegger et al., 1999; Lang et al., 2000; Fillon et al., 
2002; Khan et al., 2005), ischemic injury of the brain (Imaizumi et al., 1994; Nishida et al., 
2004), neuronal excitotoxicity (Hollister et al., 1997), memory consolidation (Tsai et al., 
2002), chronic viral hepatitis (Fillon et al., 2002), DNA damaging agents (You et al., 2004), 
vitamin D3 (Akutsu et al., 2001), psychophysiological stress (Murata et al., 2005), iron 
(Marzullo et al., 2004), glucose (Khan et al., 2005), endothelin-1 (Khan et al., 2005), 
granulocyte-macrophage colony–stimulating factor (GM-CSF) (Cowling and Birnboim 
2000), fibroblast growth factor (FGF) (Mizuno and Nishida 2001), platelet-derived growth 
factor (PDGF) (Mizuno and Nishida 2001), phorbolesters (Mizuno and Nishida 2001), 
follicle-stimulating hormone (FSH) (Alliston et al., 1997), sorbitol (You et al., 2004; Leong 
et al., 2003), heat shock (You et al., 2004; Leong et al., 2003), oxidative stress (You et al., 
2004; Leong et al., 2003), UV irradiation (You et al., 2004; Leong et al., 2003), and p53 
(Firestone et al., 2003; Maiyar et al., 1997; You et al., 2004; Maiyer et al., 1996).  
 
1.1     TABLE 1:  Stimuli that cause induction of SGK1 expression 
 
Stimuli 
 
Cell or tissue type Reference(s) 
Serum Ubiquitous Webster et al., 1993 
Glucocorticoids Ubiquitous Webster et al., 1993 
Aldosterone ASDN Chen et al., 1999; Naray-
Feges-Toth et al., 1999 
Cell shrinkage HepG2, MDCK, Waldegger et al., 1997; 
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neuroblastoma Warntges et al., 2002 
Cell swelling A6 cells Rozansky et al., 2002 
TGF-β U937, HepG2, intestine, 
fibroblasts, endothelial cells 
Waldegger et al., 1999; 
Lang et al., 2000; Fillon et 
al., 2002; Khan et al., 2005 
Chronic viral hepatitis Liver Fillon et al., 2002 
Ischemic injury of brain Brain Imaizumi et al., 1994; 
Nishida et al., 2004 
Neuronal excitotoxicity Brain, glial cells Hollister et al., 1997 
Memory consolidation Brain, hypocampus Tsai et al., 2002 
DNA damage Fibroblasts You et al., 2004 
1a,25-dihydroxyvitamin D3 Squamous cell carcinoma Akutsu et al., 2001 
Psychophysiological stress Brain, heart, kidney Murata et al., 2005 
Iron Intestine Marzullo et al., 2004 
Glucose Endothelial cells Khan et al., 2005 
Endothelin-1 Endothelial cells Khan et al., 2005 
Granulocyte-macrophage 
colony–stimulating factor 
Granulocytes Cowling and Birnboim 
2000 
Fibroblast growth factor NIH 3T3 cells Mizuno and Nishida 2001 
Platelet-derived growth 
factor 
NIH 3T3 cells Mizuno and Nishida 2001 
Phorbolesters NIH 3T3 cells Mizuno and Nishida 2001 
Follicle-stimulating 
hormone 
Rat ovarian granulosa cells Alliston et al., 1997 
Sorbitol NMuMg mammary 
epithelial cells 
You et al., 2004; Leong et 
al., 2003 
UV radiation NMuMg mammary 
epithelial cells 
You et al., 2004; Leong et 
al., 2003 
Heat shock NMuMg mammary 
epithelial cells 
You et al., 2004; Leong et 
al., 2003 
Oxidative stress/H2O2 NMuMg mammary 
epithelial cells 
You et al., 2004; Leong et 
al., 2003 
PPARγ ASDN Hong et al., 2003 
p53 Mammary epithelial cells Firestone et al., 2003; 
Maiyar et al., 1997; You et 
al., 2004 
 
 
1.2   The SGK1 Isoforms SGK2 and SGK3 
 
There are two paralogs of SGK1, SGK2 and SGK3/CISK, which share 80% amino 
acid identity with SGK1 and with each other in their catalytic domains (Kobayashi et al., 
1999; Liu et al., 2000; Dai et al., 1999). The three enzymes differ in the region N-terminal 
of the C-terminal catalytic domain: SGK2 contains a relatively short N terminus (98 amino 
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acids), with no discernable domain, whereas SGK3 has a longer N terminus (162 amino 
acids) comprising a phox homology (PX) domain (Xu et al., 2001). PX domains were 
originally found as conserved domains in the p40phox and p47phox subunits of the neutrophil 
NADPH oxidase (phox) superoxide-generating complex (Ponting 1996). These domains are 
part of many proteins involved in intracellular protein trafficking, such as the sorting nexins 
(Worby and Dixon 2002). PX domains are phosphoinositide-binding domains that appear to 
be important for localization of these proteins to membranes (especially endosomes) 
enriched in phosphoinositides. In this respect, these domains resemble other domains such 
as the pleckstrin homology (PH), FYFE, FERM and ENTH domains. PKB/Akt contains a 
PH domain in its N terminus, which is important for PKB/Akt activation by 
phosphoinositide-3 kinases (PI-3Ks). This domain enables the colocalization with the 3-
phosphoinositide-dependent protein kinase-1 (PDK-1), which is known to phosphorylate 
and activate PKB/Akt. Similarly, SGK3’s PX domain is involved in SGK3 localization and 
activity: It is necessary for phosphoinositide binding, endosomal localization, and proper 
kinase activity (Xu et al., 2001; Liu et al., 2000). Moreover, structural studies indicate that it 
may play a role in dimerization of the kinase (Xing et al., 2004). With respect to their 
physiological role(s), it has been shown in vitro that both the SGK2 and SGK3 enzymes 
have the same phosphorylation consensus as SGK1 (and PKB/Akt), namely R-X-R-X-X-
(S/T) (Kobayashi et al., 1999). It is likely, however, that other factors, such as surrounding 
amino acids, subcellular localization, or cofactors are important for the specificity of and 
functional differences between the enzymes. For example, in Xenopus A6 cells, only SGK1 
and not the coexpressed PKB modulates the activity of the epithelial Na+ channel (ENaC) 
(Artega et al., 2005). The role of SGK2 has mainly been studied in heterologous expression 
systems such as Xenopus laevis oocytes or HEK293 cells and with respect to numerous 
transport and channel proteins. These studies revealed that SGK2 can stimulate the activity 
of K+ channels such as the voltage- gated K+ channel Kv1.3 (Gamper et al., 2002; Henke et 
al., 2004), Na+,K+-ATPase (Henke et al., 2002), KCNE1 (Embark et al., 2003), ENaC 
(Friedrich et al., 2003), the glutamate transporter EEAT4 (Bohmer et al., 2004), and the 
glutamate receptors GluR6 (Strutz-Seebohm et al., 2005) and GluR1 (Strutz-Seebohm et al., 
2005a). All of these transport proteins are also stimulated in the same cellular systems by 
SGK1, SGK3, and/or PKB; hence, the physiological relevance of these findings has to be 
considered with caution. To define more precisely the role of SGK2, it will be necessary to 
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carry out additional studies, using more relevant cell or animal systems and knocking down 
SGK2 by either RNA interference protocols or by gene inactivation. SGK3/CISK, which is 
better characterized than SGK2, was identified in a screen for antiapoptotic genes (Liu et 
al., 2000) and found to act downstream of the PI-3K pathway and in parallel with PKB/Akt. 
Moreover, it was demonstrated to phosphorylate and inhibit Bad (a proapoptotic protein) 
and FKHRL1, a proapoptotic transcription factor. Knockout (KO) mice have been 
generated; these mice are viable and fertile and have normal Na+ handling and glucose 
tolerance, as opposed to the KO mice of SGK1 or PKB/Akt2 (McCormick et al., 2004; 
Garofalo et al., 2003; Wulff et al., 2002; Cho et al., 2001). However, they display after birth 
a defect in hair follicle development, a defect preceded by disturbances in the β-
catenein/Lef1 gene regulation (McCormick et al., 2004). Like SGK2, SGK3 has been 
implicated in the regulation of numerous transporters and channels, including K+ channels 
(Gamper et al., 2002; Henke et al., 2004; Embark et al., 2003), Na+,K+-ATPase (Henke et 
al., 2002), the glutamate transporter EEAT1 (Boehmer et al., 2003), the cardiac voltage-
gated Na+ channel SCN5A (Boehmer et al., 2003), ENaC (Friedrich et al., 2003), Na+-
dicarboxylate cotransporter 1 (Boehmer et al., 2004), the chloride channel ClCa/barttin 
(Embark et al., 2004), the epithelial Ca2+ channel TRPV5 (Embark et al., 2004), the Na+-
phosphate cotransporter NaPi1b (Palmada et al., 2004), the amino acid transporter ASCT2 
(Palmada et al., 2005), GluR1, and GluR6 (Strutz-Seebohm et al., 2005; Strutz-Seebohm et 
al., 2005a). For the same reasons mentioned above for SGK2, additional studies on SGK3 
will be necessary to evaluate the physiological relevance of these findings. 
 
1.3.   Regulation of SGK1 by Phosphorylation 
 
Many AGC kinases contain in their catalytic domain and in the C-terminal region 
conserved phosphorylation motifs. The motif in the catalytic domain, situated on the so-
called activation loop (A-loop), was first identified in PKB/Akt and was shown to be a 
target of PDK-1 (Alessi et al., 1997; Stokoe et al., 1997). Hence, PKB/Akt is a kinase 
regulated by an upstream kinase, which depends on the PI-3K system. As outlined above, 
both PKB/Akt and PDK-1 contain a PH domain, enabling them to interact with 
phosphoinositides [phosphatidylinositol-(3,4)-biphosphate and phosphatidylinositol- 
(3,4,5)-triphosphate, or PtdIns(3,4)P2 and PtdIns(3,4,5)P3, respectively] generated by PI-
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3K. The PH domain recruits both kinases to membranes and allows PDK-1 to phosphorylate 
PKB/Akt. This activation is very fast (approximately 2 minutes after stimulation with 
insulin or growth factor) (Vanhaesebroeck and Alessi 2000). PDK-1-dependent 
phosphorylation sites are also found in PKA (Cheng et al., 1998), PKCζ (Chou et al., 1998; 
Le Good et al., 1998), p70S6K (Alessi et al., 1997; Pullen et al., 1998), and the SGK 
paralogs (Kobayashi and Cohen 1999; Park et al., 1999). In SGK1 it is Thr256 in the         
A-loop of the catalytic domain. However, although SGK1 is also dependent on the PI-3K 
pathway and on PDK-1 activity, the mode of activation of SGK1 is different from that of 
PKB/Akt, as SGK1 does not contain a PH or any similar phosphoinositide-binding domain. 
SGK1 becomes phosphorylated on Ser422 in the C-terminal region termed the hydrophobic 
motif (H-motif) by a so-far unknown kinase that is PI-3K-dependent. This kinase activity 
has been referred to as PDK-2 or H-motif kinase activity; its activity can be indirectly 
inhibited by PI-3K inhibitors such as Wortmannin or LY-294002 (Kobayashi and Cohen 
1999; Park et al., 1999) or mimicked by mutation of Ser422 to aspartate, thereby generating 
a constitutively active kinase. Phosphorylation of Ser422 or mutation to aspartate 
transforms SGK1 into a substrate for PDK-1, which binds via its PDK- 1-interacting 
fragment (PIF)–binding pocket to the H-motif on SGK1, promoting phosphorylation of the 
A-loop motif and consequently activation of SGK1 (Biondi et al., 2001). Hence, in this 
context, and in contrast to PKB/Akt activation, phosphorylation of SGK1 by PDK-1 is 
independent of phosphoinositides or the PH domain in PDK-1. This renders the activation 
of SGK1 much slower (with maximal activation occurring typically after 10 to 40 minutes) 
than that of PKB/Akt. The physiological significance of this difference is unclear but 
suggests a bigger need for rapid activation of PKB/Akt than of SGK1. Changes in Na+ 
balance (whereby SGK1 is activated via aldosterone) usually occur less rapidly than 
changes in blood glucose levels (whereby PKB/Akt is activated). cAMP also may activate 
SGK1 (Perrotti et al., 2001). In this context, a consensus sequence for PKA-dependent 
phosphorylation surrounding Thr369 (K-K-I-T-P), which is necessary for cAMP-dependent 
phosphorylation, was identified. However, this consensus for phosphorylation is imperfect, 
and other groups have been unable to detect activation of SGK1 by cAMP under conditions 
in which cAMP stimulated the phosphorylation of the transcription factor CRE 
phosphorylated and activated by various MAP kinases, namely by bone marrow kinase 
(BMK) [also known as extracellular signal–regulated kinase 5 (ERK5)] or by p38α 
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(Hayashi et al., 2001; Meng et al., 2005). Both these kinases phosphorylate SGK1 on Ser78, 
which lies outside of the catalytic domain. Such phosphorylation leads to an increase in 
Sgk1 activity, independent of the phosphorylation state of Thr256 (in the A-loop). It is not 
known how this phosphorylation activates SGK1, but other kinases are also activated by 
phosphorylation outside of the catalytic domain (Stokoe et al ., 1992). SGK1 has also been 
reported to interact with WNK1 (with no lysine kinase 1), a kinase playing a role in Na+ 
homeostasis and blood pressure control. In this process WNK1 is able to activate SGK1. 
The mechanism of activation is not completely clear, but it may involve phosphorylation of 
Ser422 or mutation of Ser422 to aspartate in addition to phosphorylation of Thr256, 
suggesting a similar mechanism as that involved in the activation via PDK-1. However, 
direct phosphorylation of SGK1 by WNK1 has not been demonstrated (Xu et al., 2005). 
 
1.4   Tissue Distribution of SGK Isoforms 
 
SGK isoforms are expressed in numerous tissues and cell lines. Among the three 
kinases, SGK1 (Webster et al., 1993; Waldegger et al., 1997; Kobayashi et al., 1999) and 
Sgk3 (Kobayashi et al., 1999) show the broadest distribution, with expression in many 
tissues including the brain, placenta, lung, liver, pancreas, kidney, heart and skeletal muscle. 
In situ hybridization studies localized SGK1 mRNA in several epithelial and/or 
nonepithelial cells within the brain (Warntges et al., 2002; Nishida et al., 2004; Tsai et al., 
2002; Stichel et al., 2005; Gonzalez-Nicolini and McGinty 2003), eye (Rauz et al., 2003; 
Rauz et al., 2003a), lung (Waerntges et al., 2002), liver (Fillon et al., 2002), ovary (Alliston 
et al., 2000), pancreas (Klingel et al., 2000), intestine (Waldegger et al., 1999), and kidney 
(Chen et al., 1999; Friedrich et al., 2002; Huber et al., 2001). SGK1 mRNA expression is 
established very early in embryonic development, as indicated by in situ hybridizations on 
whole-mount preparations of mouse embryo (Lee et al., 2001). By embryonic day (E) 8.5, 
SGK1 is already highly expressed in the decidua and yolk sac. By days E9.5– E12.5 it is 
found in the developing heart, eye, and lung, and it becomes highly expressed by days 
E13.5–E16.5 in the brain choroid plexus, kidney distal tubules, bronchi/brochioli, adrenal 
glands, liver, thymus, and intestine (Lee et al., 2001). In contrast to SGK1 and SGK3, 
SGK2 reveals a more restricted distribution and is highly abundant only in the liver, kidney, 
and pancreas, where it is found in two different SGK2 species, referred to as SGK2α and 
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SGK2β (Kobayashi et al., 1999). SGK isoform expression varies also between cell lines 
cultured in vitro. Similar to its expression pattern in vivo, SGK1 is broadly expressed in 
cultured cells and is readily detectable in, for example, hepatoma cells, fibroblasts, and 
mammary tumor cells (Webster et al., 1993; Kobayashi et al., 1999). By contrast, SGK2 
mRNA is expressed in hepatoma cells but not in fibroblasts, whereas SGK3 is found in 
fibroblasts but not in hepatoma cells. Remarkably, all three SGK isoforms are expressed in 
cells derived from the renal cortical collecting duct (Naray-Fejes-Toth et al., 2004).  
 
1.5 Role of SGK1 in Aldosterone Dependent Na+ Reabsorption 
 
Although SGK isoforms are expressed in various tissues and cell types, the role of 
SGK1 in aldosterone-dependent regulation of Na+ homeostasis is the best-studied function 
of these kinases with respect to epithelial ion transport. The kidneys play a pivotal role in 
the maintenance of Na+ homeostasis. Urinary Na+ excretion must be tightly regulated to 
maintain a constant extracellular volume during varying dietary Na+ intake and extrarenal 
Na+ losses. The final control of renal Na+ excretion is achieved by the ASDN i.e. the late 
distal convoluted tubule, the connecting tubule, and the cortical as well as the medullary 
collecting ducts (CCD and MCD respectively) (Loffing et al., 2001). Transepithelial Na+ 
transport in these segments is accomplished by Na+ entry into the epithelial cells via the 
epithelial Na+ channel (ENaC) in the luminal membrane and by exit of Na+ through the Na+, 
K+-ATPase in the basolateral plasma membrane. ENaC represents the rate limiting step in 
this process and is highly regulated (Kellenberger and Schild 2002). It is composed of three 
subunits (α, β and γ) (Canessa et al., 1994; Canessa et al., 1994; Lingueglia et al., 1993; 
Lingueglia et al., 1994) with a stoichiometry of 2α1β1γ (Firsov et al., 1998), although other 
stoichiometries have also been proposed (octa- or nonamers) (Eskandari et al., 1999; Snyder 
et al., 1998). Its subunits have a similar topology, with two transmembrane domains, one 
extracellular loop, and two cytoplasmic ends (Renard et al., 1994; Canessa et al., 1994; 
Snyder et al., 1994). Each subunit also contains, at its C-terminal end, a PY-motif (P-P-X-
Y, where P is a proline, Y a tyrosine, and X any amino acid), which is known as 
protein:protein interaction motifs that can interact with tryptophan (W)-rich WW domains 
(Chen and Sudol 1995; Staub and Rotin 1996). The importance of these PY-motifs for 
ENaC regulation has been recognized by the findings that most cases of Liddle’s syndrome 
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(Liddle et al., 1963), an inherited form of salt-sensitive hypertension are caused by 
mutations in the genes encoding β- and γ -ENaC (Hansson et al., 1995; Shimkets et al., 
1994). These mutations invariably cause either the deletion or the mutation of the PY-motifs 
on these subunits. When such Liddle channels are expressed in heterologous systems, 
increases in both the density at the cell surface and the open probability of ENaC are 
observed (Firsov et al., 1996; Snyder et al., 1995; Schild et al., 1995; Schild et al., 1996). 
Loffing and his coworkers, has demonstrated that these PY-motifs are the binding sites for 
ubiquitin-protein ligases of the Nedd4/Nedd4-like family (Kamynina et al., 2001; Kamynina 
et al., 2001a ) and particularly of Nedd4-2 (Kamynina et al., 2001; Kamynina et al., 2001a; 
Snyder et al., 2004). It is thought that Nedd4-2 binds via its WW domains with the PY-
motifs of ENaC and ubiquitylates ENaC on its α and γ subunits, consequently leading to the 
internalization and degradation of ENaC in the endosomal/lysosomal system (Snyder et al., 
2004). In Liddle’s syndrome, this mechanism is impaired owing to the inactivation of a PY-
motif, causing the accumulation of ENaC at the plasma membrane (Kamynina and Staub 
2002). The activity of ENaC and the Na+, K+-ATPase is tightly regulated by aldosterone 
and by SGK1 (Kellenberger and Schild 2002; Vallon et al., 2005; Bhargava et al., 2004). 
Experiments in heterologous expression systems (i.e., X. laevis oocytes) revealed that 
coexpression of either ENaC or Na+,K+-ATPase (Zecevic et al., 2004; Setiawan et al., 2002) 
with SGK1 profoundly increases the activity of both Na+-transporting proteins. Likewise, 
SGK2 and SGK3 stimulate ENaC (Friedrich et al., 2003) and Na+,K+-ATPase (Henke et al., 
2002). The stimulatory effect of SGK1 on ENaC is related both to an increased number of 
channels in the plasma membrane (Lang et al., 2000; Loffing et al., 2001; Alvarez de la 
Rosa et al., 1999) and an activation of channels already present in the membrane (Diakov 
and Korbmacher 2004). The first effect likely involves the action of Nedd4-2, as there are 
several consensus phosphorylation motifs (2–3 depending on the splice variant) on Nedd4-2 
and a PY-motif on SGK1 that may serve as a binding site for Nedd4-2. In Xenopus oocytes, 
SGK1 induces Nedd4-2 phosphorylation on two of these phosphorylation sites (primarily 
Ser444, but also Ser338) (Embark et al., 2004; Palmada et al., 2004; Debonneville et al., 
2001), which decreases the interaction of Nedd4-2 with ENaC and finally leads to an 
enhanced expression and activity of ENaC at the cell surface (Debonneville et al., 2001). 
This inhibitory effect of SGK1 on Nedd4-2 likely involves 14-3-3 proteins as 
phosphorylation of Ser444 in Nedd4-2 creates a possible binding site for such proteins 
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(consensus: R-S-X-pS-X-P). Indeed, in X. laevis oocytes, SGK1 increases the binding of 
14-3-3 to Nedd4-2 in a phosphorylation-dependent manner, a dominant-negative 14-3-3 
mutant profoundly attenuates SGK1-dependent stimulation of ENaC, and overexpression of 
the 14-3-3 protein impairs Nedd4-2-dependent ubiquitylation of ENaC (Ichimura et al., 
2005).  
In addition to this indirect action of SGK1 on ENaC cell surface abundance, it was 
proposed that SGK1 can directly interact with ENaC (Wang et al., 2001) and increase ENaC 
channel activity by phosphorylating the α-ENaC subunits (Diakov and Korbmacher 2004). 
Diakov & Korbmacher (2004) used outside-out membrane patches of X. laevis oocytes 
expressing rat ENaC to demonstrate that addition of recombinant, constitutively active 
SGK1 directly stimulates ENaC currents two- to threefold. An alanine mutation of the 
serine residue in the SGK1 consensus R-X-R-X-X-S phosphorylation motif abolishes the 
stimulatory effect on ENaC in this experimental setting. Experiments in native Xenopus A6 
cells expressing endogenous SGK1 and ENaC further confirmed that the action of SGK1 on 
ENaC is complex and likely involves (a) increases in the subunit abundance in the plasma 
membrane and (b) activation of channels already in the plasma membrane combined with 
an increase in ENaC open probability (Alvarez de la Rosa et al., 2004). However, in this 
model the stimulatory effect on ENaC channel activity cannot be explained by a direct 
SGK1-dependent phosphorylation of α-ENaC because Xenopus α-ENaC does not contain 
the SGK1 consensus phosphorylation motif. That direct phosphorylation of ENaC at the 
SGK1 consensus site is not essential for ENaC activation is also supported by data from 
Lang and coworkers (Lang et al., 2000; Friedrich et al., 2002) that showed that channels 
with a serine-to-alanine mutation within the consensus site of α-ENaC are still rigorously 
upregulated by coexpression of SGK1 in Xenopus oocytes. NDRG-2, which is an 
aldosterone-induced protein in the ASDN, is another target of SGK1 (Boulkroum et al., 
2002; Murray et al., 2004). Although the functional role of NDRG-2 in the ASDN is not 
known, this protein may also have some function in the SGK1-dependent signaling cascade 
related to Na+ transport. As an aldosterone-induced protein, SGK1 is thought to mediate at 
least some of the physiological effects of aldosterone on ENaC and Na+,K+-ATPase. The 
stimulatory effect of aldosterone (or of dexamethasone) on SGK1 expression has now been 
firmly documented in several studies on various in vitro and in vivo systems, including 
Xenopus A6 cells (Bhargava et al., 20004), primary rabbit CCD cells (Narey-Fejes-Toth et 
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al., 1999), mouse inner MCD cells (Gumz et al., 2003), mouse mpkCCDcl4 (Flores et al., 
2005), mouse M1 cells (Helms et al., 2003 ), and mouse and rat kidneys (Chen et al., 1999; 
Loffing et al., 2001; Bhargava et al., 2001). Corticosteroids rapidly (within 30 minutes) 
induce SGK1 at the mRNA and/or protein levels. This induction precedes or at least 
coincides with enhanced phosphorylation of Nedd4-2 (Flores et al., 2005), the activation of 
transepithelial Na+ transport in cultured renal epithelia (Naray-Fejes-Toth et al., 1999; 
Bhargava et al., 2004; Flores et al., 2005), and reduced renal Na+ secretion in intact animals 
(Bhargava et al., 2001). At least part of the stimulatory effect of aldosterone on SGK1 
appears to be mediated by activation of the MR, as indicated by findings in primary rabbit 
collecting duct cells in vitro (Naray-Fejes-Toth et al., 1999) and kidneys in vivo (Bhargava 
et al., 2001). Consistently, physiologically relevant concentrations of aldosterone are 
sufficient to significantly induce SGK1 mRNA in the renal cortex and outer medulla            
(Muller et al., 2003). The physiological importance of aldosterone in SGK induction is also 
supported by the fact that dietary Na+ restriction, which physiologically increases plasma 
aldosterone, induces SGK1 mRNA in the renal cortex (Farjah et al., 2003). The aldosterone-
dependent induction of SGK1 occurs specifically in the ENaC-positive cells of the ASDN, 
whereas SGK1 expression in other nephron portions such as the thick ascending limb or the 
proximal tubule is not increased by aldosterone. Likewise, the high level of expression of 
SGK1 in the renal papilla is not further stimulated by aldosterone, suggesting that SGK1 
expression at this site is controlled by factors other than aldosterone. The renal papilla plays 
an important role for the urinary concentration mechanism, and the cells in the renal papilla 
can be exposed to a large variation in extracellular osmolarity depending on the 
requirements for diuresis to antidiuresis. SGK1 expression is strongly modulated by osmotic 
cell shrinkage and swelling (Waldegger et al., 1997; Rozansky et al., 2002), and it is 
therefore conceivable that SGK1 participates in the functional adaptation of the renal papilla 
cells to fluctuation of extracellular osmolarity. Consistent with this notion, recent data 
suggest that SGK1 mediates the osmotic induction of the type A natriuretic peptide receptor 
(NPR-A) in rat inner MCD cells (Chen et al., 2004). Aldosterone also controls SGK1 
expression in the distal colon (Coric et al., 2004; Bhargava et al., 2001). Aldosterone-
dependent Na+ reabsorption at this site may help to limit extrarenal Na+ losses during 
conditions of dietary Na+ restriction. Transepithelial Na+ transport is achieved mainly by 
epithelial cells that are situated at the tips of colonic crypts and that express high levels of 
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ENaC (Coric et al., 2004) and Sgk1 (Waldegger et al., 1999; Coric et al., 2004). In spite of 
these data pointing to aldosterone-dependent regulation of ENaC via SGK1, recent Western 
blot and immunohistochemical studies on rat kidney and colon, which reported no or rather 
modest aldosterone-dependent induction of SGK1 at the protein level, were interpreted to 
question the significance of aldosterone-dependent induction of SGK1 for ENaC-mediated 
Na+ transport regulation (Coric et al., 2004). Support for a functional significance of SGK1 
in regulation of transepithelial Na+ transport comes from experiments in X. laevis A6 cells 
and in mouse M1 CCD cells. Transfection of A6 or M1 cells with SGK1 leads to an 
increase in transepithelial Na+ transport, whereas transfection of a dominant-negative 
“kinase-dead” SGK1 mutant or an antisense SGK1 transcript abolishes dexamethasone- 
and/or insulin-dependent regulation of transepithelial Na+ transport (Alvarez de Rosa et al., 
2003; Faletti et al., 2002). Likewise, the use of interfering RNA to knockdown SGK1 
expression in A6 cells results in a significant reduction in SGK1 protein levels and a ~50% 
reduction in dexamethasone-induced short-circuit currents (Bhargava et al., 2004). 
Consistent with these in vitro findings, experiments in SGK1 KO (sgk1-/-) mice supported 
the importance of SGK1 for aldosterone-dependent regulation of renal Na+ transport (Wulff 
et al., 2002). Under a standard diet, the KO mice have unaltered Na+ excretion as compared 
to their wildtype littermates. However, plasma aldosterone levels are significantly increased 
in sgk1-/- mice, suggesting extracellular volume contraction. Under dietary Na+ restriction, 
activated compensatory mechanisms are no longer sufficient to keep the mice in Na+ 
balance, and mice disclosed significant loss in renal NaCl and in body weight. Experiments 
on collecting ducts perfused ex vivo revealed significantly lower transepithelial amiloride-
sensitive potential differences, consistent with a reduced Na+ transport activity in the CCD. 
Although apical localization of ENaC was seen in both Na+-restricted sgk+/+ and sgk1-/- 
mice, the apical localization of ENaC is inappropriately low in the sgk1-/- mice given the 
severalfold higher plasma aldosterone levels in the KO mice. Nevertheless, these data, 
together with the rather mild phenotype of sgk1-/- mice, as compared to the much more 
severe and life-threatening phenotypes of MR or ENaC KO mice, suggest that (a) 
aldosterone-dependent control of ENaC function does not solely rely on the induction and 
activation of SGK1 and (b) some redundancy exists in the signal transduction pathway that 
controls ENaC activity. Consistent with these ideas, Loffing and his coworkers found 
significant phosphorylation of the SGK1 target Nedd4-2 in mouse mpkCCDcl4 cells in vitro 
 19 
and in rat collecting ducts in vivo in the absence of any aldosterone and detectable SGK1 
protein expression (Flores et al., 2005). In addition to aldosterone-dependent regulation of 
renal Na+ reabsorption, SGK1 appears to be involved also in the regulation of aldosterone-
induced salt appetite. Sgk1+/+ and sgk1-/- mice show a similar salt intake under standard 
conditions. Treatment with the synthetic aldosterone analogue deoxycorticosterone-acetate 
(DOCA) increases Na+ intake much more in Sgk1+/+ mice than in sgk1-/- mice. The 
underlying mechanism for the reduced mineralocorticoid-induced salt intake is unclear 
(Vallon et al., 2005).  
 
1.6 Role of SGK1 in Renal K+ Secretion 
 
Aside from its stimulatory effect on renal Na+ reabsorption, aldosterone has strong 
kaliuretic action. Renal K+ secretion also takes place in the ASDN and is likely mediated by 
the renal outer medullary K+ channel ROMK. ROMK is coexpressed with ENaC in the 
ASDN cells, and Na+ reabsorption via ENaC provides the necessary driving force for K+ 
secretion. Consistently, pharmacological inhibition (i.e., by amiloride) or genetic loss of 
function [i.e., pseudohypoaldosteronism (PHA) type 1] of ENaC lower renal K+ secretion 
and predispose one to hyperkalemia. It remains unresolved whether the kaliuretic effect of 
aldosterone is entirely secondary to the activation of ENaC-mediated Na+ reabsorption or 
whether aldosterone directly regulates ROMK function. Patch-clamp studies on rat CCDs 
found no measurable effect of acute aldosterone administration on K+ channel number, open 
probability, or conductance (Palmer et al., 1994). However, some data suggested that 
aldosterone induces renal K+ secretion already at aldosterone concentrations that do not 
exhibit any measurable effect on urinary Na+ excretion (Bhargava et al., 2001). Moreover, 
high K+ intake increases ROMK activity more efficiently in intact rats than in 
adrenalectomized animals, suggesting that aldosterone may have at least a permissive effect 
on ROMK activation (Palmer et al., 1994). Consistent with a possible role of aldosterone in 
ROMK regulation, recent studies in heterologous expression systems advocated a 
regulatory action of aldosterone-induced SGK1 on ROMK cell surface activity and 
abundance (Palmada et al., 2003, Palmada et al., 2003a). The regulatory role of SGK1 with 
regard to ROMK may be indirect via increased interaction with the Na+, H+ exchanger–
regulating factor 2 (NHERF2) (Palmada et al., 2003, Palmada et al., 2003a) or direct via 
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increased phosphorylation of ROMK at a serine residue within the canonical SGK1 
consensus phosphorylation motif (Yoo et al., 2003). The in vivo significance of SGK1 in 
regulation of renal K+ transport was recently analyzed in SGK1 KO mice. These mice 
indeed show a disturbed adaptation to an acute and chronic K+ load, but, as indicated by 
electrophysiological and immunohistochemical data obtained from these mice after a 
chronic potassium load, this maladaptation likely is related to altered ENaC (or Na+,K+-
ATPase) activity in the ASDN cells rather than to inhibition of ROMK cell surface targeting 
or activity (Huang et al., 2004). 
 
1.7   Serum and glucocorticoid-inducible kinase 1 and blood pressure 
 
A potential role for impaired regulation of SGK1 in NaCl-sensitive hypertension 
was suggested from studies in Dahl rats: whereas a high NaCl diet lowered renal expression 
of SGK1 and did not affect blood pressure in Sprague–Dawley rats, the NaCl-sensitive Dahl 
rats showed an increased renal expression of SGK1 associated with an increase in blood 
pressure (Farjah et al., 2003). Unfortunately, the nephron site of enhanced SGK1 expression 
was not determined. As outlined above, activation as well as gain-of-function mutations of 
SGK1 could increase renal Na+ reabsorption and, thus potentially, blood pressure through 
affecting various transport systems including (1) NHE3 and KCNQ1/KCNE1 in proximal 
tubule, (2) BSC-1 in thick ascending limb, (3) ENaC in ASDN and (4) basolateral Na+/K+-
ATPase in all nephron segments. Moreover, preliminary studies provided evidence that the 
increase in NaCl appetite in response to the mineralocorticoid deoxycorticosterone acetate 
is attenuated in mice lacking SGK1 (Vallon et al., 2005), indicating that SGK1 may play at 
least a dual role in mineralocorticoid-regulated NaCl homeostasis. SGK1- dependence of 
both NaCl intake and renal NaCl reabsorption would make the kinase an attractive 
candidate gene for arterial hypertension with gain-of function mutations stimulating NaCl 
intake in the presence of an impaired ability to excrete NaCl through the kidney. A study by 
Busjahn et al. (2002) indeed identified two polymorphisms of the SGK1 gene, one 
synonymous polymorphism in exon 8 (E8CC/CT) and one in intron 6 (I6CC) that correlate 
with enhanced blood pressure in twin studies. Individuals carrying the gene variants that 
associated with higher blood pressure also have an increased body mass index that may be 
due to stimulation of Na+/glucose transporter SGLT1 in the intestine (Dieter et al., 2004). 
 21 
Moreover, they have a tendency for shorter cardiac action potential possibly due to 
enhanced activation of KCNE1/KCNQ1 (Busjahn et al., 2004). In contrast, Trochen et al. 
(Trochen et al., 2004) recently studied the aforementioned polymorphisms in exon 8 and 
intron 6 in unrelated Caucasian healthy controls and essential hypertensive patients, and  
concluded that these polymorphisms do not have a significant effect on blood pressure in 
subjects without renal disease, do not account for the occurrence of renal disease per se and 
are not determinants of progressive renal failure. The different results with regard to blood 
pressure could be due to relatively small sample size and the fact that the effect of the gene 
variant in twins has been small (Busjahn et al., 2002) and may not be apparent in selected 
populations, illustrating the problems in determining genetic influences in complex traits. In 
any case, additional effort is needed to elucidate the impact of SGK1 on blood pressure 
control and genesis of hypertension. 
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Figure 1. Proposed interaction between SGK1, epithelial Na+ channel (ENaC), and renal 
outer medullary K+ channel (ROMK) in aldosterone-sensitive distal nephron. Aldosterone 
stimulates the expression of ENaC, ROMK and SGK1. Activation of SGK1 (Sgk1a) 
requires phosphorylation of the kinase, which, in addition to other factors, can be induced 
by binding of insulin (Ins) or arginine vasopressin (AVP) to their basolateral receptors. 
Sgk1 is not absolutely required for insertion of ENaC or ROMK into the apical membrane, 
explaining the mild phenotype of SGK1-deficient mice under standard NaCl and K+ diet.                 
SGK1-dependent upregulation of Na+ reabsorption, however, is required under reduced 
dietary NaCl intake as well as for upregulation of renal K+ excretion in response to 
increased dietary K+ intake. SGK1a increases Na+ reabsorption by activating Na+-K+-
ATPase and enhancing the abundance in the cell membrane of ENaC through inhibition of 
ubiquitin ligase Nedd4–2 mediated internalization of ENaC. Effects of SGK1a on ENaC 
and Na+-K+-ATPase increase the electrical driving force for paracellular Cl+ reabsorption as 
well as the electrochemical driving force for K+ secretion through ROMK. In addition, 
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SGK1 may enhance the abundance of ROMK in the apical membrane by synergizing with 
NHERF2. MR, mineralocorticoid receptor; PKA, protein kinase A; PDK, 3-
phosphoinositide-dependent kinase. 
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Figure 2: (1) Acute hyperglycemia increases plasma insulin (Ins) concentration, which 
activates SGK1 (SGK1a). Activated SGK1 stimulates the electrogenic Na+/glucose 
cotransporter SGLT1 by inhibiting Nedd4-2- mediated retrieval of SGLT1 from the cell 
membrane, and to prevent membrane depolarization SGK1 co-activates the potassium 
channel KCNQ1/KCNE1. This enhances the glucose reabsorption capacity of proximal 
tubule to prevent postprandial glucosuria. (2) SGK1 activates both Na+/H+ exchanger NHE3 
and electrogenic Na+/dicarboxylate transporter NaDC-1 by a mechanism involving NHE-
regulating factor 2 (NHERF2). Under conditions of metabolic acidosis, SGK1 may serve to 
coordinate proton secretion through NHE3 and citrate reabsorption through NaDC-1 with 
citrate being used for bicarbonate generation. Stimulation of basolateral Na+/K+-ATPase by 
SGK1 increases the electrochemical gradient for Na+ reabsorption across the luminal 
membrane. The factors that control the expression of SGK1 in proximal tubule remain to be 
determined. GR, glucocorticoid receptor; PI3K, phosphatidylinositol 3-kinase; PDK, 3-
phosphoinositidedependent kinase. 
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II. AIMS OF THE STUDIES 
The aim of the present work was to answer the following questions: 
Study 1:  What is the influence of SGK1 on renal function and systolic blood pressure   
                 during high fat diet and high salt diet?  
Study 2:  What is the role of SGK1 in the hypertensive effect of combined treatment with   
                 fructose and salt load?  
Study 3:  What is the role of SGK1 in the regulation of electrolyte metabolism and blood   
                pressure by the glucocorticoid dexamethasone?  
Study 4:  What is the role of SGK1 in salt sensitivity of glucose tolerance and peripheral   
                glucose uptake? 
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II. 1. Study 1:  Influence of SGK1 on renal function and systolic blood pressure during   
                           high fat diet and high salt diet 
 
Expression of the serum and glucocorticoid inducible kinase SGK1 (Firestone et al., 
2003) is strongly upregulated by mineralocorticoids (Bhargava et al., 2001; Brennan and Fuller 
2000; Chen et al., 1999; Djelidi et al., 2001; Loffing et al., 2001; Narey-Fejes-Toth et al., 1999; 
Pearce 2003; Shigaev et al., 2000; Verrey et al., 2003). For activation, SGK1 requires 
phosphorylation which is accomplished by the phosphoinositide dependent kinase PDK1 
(Biondi et al., 2001; Kobayashi and Cohen 1999; Park et al., 1999). Stimulators of SGK1 
activity include insulin which activates SGK1 through a signalling pathway involving 
phosphatidylinositide 3 kinase and PDK1 (Kobayashi and Cohen 1999).  
 SGK1 interacts with the epithelial Na+ channel ENaC (Wang et al., 2001) and 
coexpression of SGK1 markedly enhances the activity of ENaC heterologously expressed in 
Xenopus oocytes (Alvarez de la Rosa et al., 1999; Bohmer et al., 2000; Chen et al., 1999; 
Lang et al., 2000; Narey-Fejes-Toth et al., 1999; Wagner et al., 2001) and in A6 cells 
(Alvarez et al., 2004; Faletti et al., 2002; Rozansky et al., 2002; Verrey et al., 2003). SGK1 
increases ENaC in part by phosphorylation of the ubiquitin ligase Nedd4-2 (Debonneville et 
al., 2001; Snyder et al., 2002) which ubiquitinates ENaC thus preparing the channel protein 
for clearance from the cell membrane and subsequent degradation (Staub et al., 1997). 
Phosphorylation of Nedd4-2 by SGK1 reduces the affinity of the enzyme to the target 
proteins and thus disrupts the ubiquitination of ENaC leading to enhanced ENaC channel 
protein abundance in the cell membrane (Alvarez de la Rosa et al., 1999; Lang et al., 2000; 
Wagner et al., 2001). Beyond that SGK1 may regulate ENaC activity by more direct 
interaction (Diakov et al., 2004) 
 SGK1 is expressed in the aldosterone sensitive distal nephron (Alvarez and Canessa 2003; 
Loffing et al., 2001) and the stimulation of ENaC by SGK1 is considered to participate in the 
regulation of renal Na+ excretion by aldosterone, insulin and IGF-1 (Blazer-Yost  et al., 
1998; Blazer-Yost et al., 1999; Blazer-Yost et al., 2004; Wang et al., 2001). Besides ENaC, 
SGK1 enhances the activity of further renal transport systems, including the apical K+ 
channel ROMK (Palmada et al., 2003; Yun et al., 2002), the Na+/K+-ATPase (Henke et al., 
2002; Setiawan et al., 2002; Zecevic et al., 2004 ), the Na+, K+, 2Cl- cotransporter NKCC2 
(Lang et al., 2000), the epithelial Ca2+ channel TRPV5 (Embark et al., 2004; Palmada et al., 
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2005), the Na+/H+ exchanger NHE3 (Yun  2003; Yun et al., 2002) and the K+ channel 
KCNE1 (Embark et al., 2003).  
 Considering the significance of renal Na+ transport for blood pressure regulation 
(Lifton 1996; Luft 2004), the effects of SGK1 on ENaC were expected to influence blood 
pressure. As a matter of fact, moderately enhanced blood pressure is observed in individuals 
carrying a variant of the SGK1 gene affecting as many as 5% of unselected Caucasians 
(Busjahn et al., 2002; Busjahn and Luft 2003). Most recent evidence disclosed a relatively 
strong correlation between insulinemia and blood pressure in individuals carrying this 
SGK1 gene variant suggesting a particular role of SGK1 in the hypertension paralleling 
hyperinsulinemia (von Wowern et al., 2005).  
Gene targeted mice lacking SGK1 (sgk1-/-) show normal Na+ excretion and blood 
pressure under normal salt intake, but their ability to retain Na+ and maintain blood pressure 
under a salt deficient diet is impaired (Wulff et al., 2002). In contrast to the mild phenotype of 
the sgk1-/- mouse, targeted disruption of the mineralocorticoid receptor in mice leads to severe 
salt wasting (Berger et al., 1998) and the ENaC knockout mouse is not viable (Hummler et al., 
1996). Thus, SGK1 is not required for the function of ENaC but significantly contributes to, 
yet does not fully account for, the effects of mineralocorticoids in the kidney. The role of 
SGK1 in preventing a decrease of blood pressure following salt depletion does not necessarily 
imply that the lack of SGK1 protects from an increase of blood pressure following excessive 
salt intake which was expected to decrease plasma aldosterone concentrations and thus to 
decrease SGK1 expression in wild type mice. Thus, high salt diet could dissipate the difference 
between sgk1-/- mice and wild type mice. Thus, the question arises whether and under which 
conditions SGK1 may be relevant for blood pressure increase. 
The present study has been performed to explore the influence of SGK1 on renal 
function and systolic blood pressure during high fat diet and high salt diet, which have both 
been shown to favour increase of blood pressure (Boustany et al., 2004; Cook et al., 2004; 
Cubeddu et al., 2000; Dobrian et al., 2003; Grant et al., 2002; Jang et al., 2004; Laffer et al., 
2004; Ogihara et al., 2002; Rocchini et al., 2004). 
  
[The studies referring to these aims, which were displayed in the further sections, have been 
published as an original publication (Huang and Boini et al., 2006a)] 
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II. 2. Study 2:  Role of SGK1 in the hypertensive effect of combined treatment with   
                         dietary fructose and salt load 
 
Dietary fructose leads to hyperglycemia, hyperinsulinism and increase in blood 
pressure (Catena et al., 2003; Hsieh 2004; Nandhini and Anuradha 2004; Shinozaki et al., 
2004; Song et al., 2004; Zhao et al., 2003). Since insulin was observed to be antinatriuretic 
in rats, dogs and humans, a role of insulin in the development of salt-sensitive hypertension 
has been suggested (DeFronzo et al., 1976; Gupta et al., 1992; Muscelli et al., 1996). The 
antinatriuretic effect of insulin appears to result from direct action on tubular transport in 
distinct nephron segments (Catena et al., 2003; El Atat et al., 2004; Hayashida et al., 2001; 
Song et al., 2004). Insulin stimulates ENaC and may thus lead to renal retention of NaCl 
(Bickel et al., 2001; Song et al., 2004; Zhang et al., 2005), which in turn favours the 
development of hypertension (Lifton 1996; Luft 2004). The effect of insulin on ENaC 
requires activation of the Phosphatidylinositide-3 (PI3)- kinase (Blazer-Yost et al., 2003; 
Blazer-Yost et al., 2004; Tong et al., 2004). The regulation of ENaC activity by insulin may 
involve the serum and glucocorticoid inducible kinase SGK1 (Firestone et al., 2003). 
Expression of SGK1 has previously been shown to be stimulated by mineralocorticoids 
(Bhargava et al., 2001; Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; 
Loffing et al., 2001; Narey-Fejes-Toth et al., 1999; Pearce 2003; Shigaev et al., 2000; Verrey 
et al., 2003). SGK1 is activated by insulin through a signalling cascade involving PI-3 
kinase and PDK1 (Biondi et al., 2001; Kobayashi et al., 1999; Park et al., 1999). Targets of 
SGK1 action include the epithelial Na+ channel ENaC (Alvarez de la Rosa et al., 1999; 
Böhmer et al., 2000; Chen et al., 1999; Lang et al., 2000; Narey-Fejes-Toth et al., 1999; 
Wagner et al., 2001).  
Chronic fructose feeding causes arterial hypertension which is associated with 
insulin resistance and hyperinsulinemia in rats (Catena et al., 2003; Hwang et al., 1987; 
Verma et al., 1994). The present study aimed to explore the role of SGK1 in the hypertensive 
effect of combined treatment with fructose and salt load. Thus, renal electrolyte excretion and 
blood pressure were determined in SGK1 knockout mice (sgk1-/-) and their wild type 
littermates (sgk1+/+) before and during oral fructose administration with and without additional 
high salt diet.  
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 [The studies referring to these aims, which were displayed in the further sections, have been 
published as an original publication (Huang and Boini et al., 2006b)] 
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II. 3.  Study 3: Role of SGK1 in the regulation of electrolyte metabolism and blood   
                          pressure by the glucocorticoid dexamethasone  
 
The serum and glucocorticoid inducible kinase SGK1 has originally been cloned as 
glucocorticoid sensitive gene (Firestone et al., 2003) and later has been shown to be 
similarly sensitive to genomic regulation by mineralocorticoids (Bhargava et al., 2001; 
Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; Loffing et al., 2001; Narey-
Fejes-Toth et al., 1999; Pearce 2003; Shigaev et al., 2000; Verrey et al., 2003). SGK1 is 
activated by insulin (Kobayashi and Cohen 1999) through a signalling cascade involving PI-
3 kinase and PDK1 (Biondi et al., 2001; Kobayashi and Cohen 1999; Park et al., 1999).  
Nothing is known about the contribution of SGK1 to the effects of glucocorticoids 
on renal function. Previously, glucocorticoids have been reported to increase blood pressure 
(Ferrari et al., 2002; Kenyon et al., 1990; Sacerdote et al., 2005), enhance renal tubular 
sodium transport (Bonvalet 1998), or increase fractional renal calcium excretion (Boross et 
al., 1986; Ferrari et al., 2002; Suzuki et al., 1983). They have been shown to decrease 
(Ferrari et al., 2002) or increase (Akeno et al., 2000; Lee et al., 2006) plasma Ca2+ 
concentration. The increase of plasma concentration may result in part from 
demineralization of bone (Patschan et al., 2001) and the hypocalcemia from renal loss of 
Ca2+  (Ferrari et al., 2002). 
The present study explored the role of SGK1 in the regulation of electrolyte 
metabolism and blood pressure by the glucocorticoid dexamethasone. To this end, 
experiments have been performed in sgk1-/- and sgk1+/+ mice prior to and following 
dexamethasone treatment without and with additional saline load. 
 
[The studies referring to these aims, which were displayed in the further sections, have been 
submitted for publication (Boini et al., 2006c)] 
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II. 4.  Study 4:  Role of SGK1 in salt sensitivity of glucose tolerance and peripheral   
                          glucose uptake 
 
Excessive salt intake may impede cellular glucose uptake in peripheral tissues and 
thus lead to delayed decrease of plasma glucose concentrations following a glucose load 
(Cheng et al., 2001; Gaboury et al., 1994; Giner et al., 2001; ter Maaten et al., 1999; 
Vincent et al., 2003). Mechanisms accounting for the salt sensitivity of peripheral glucose 
uptake have remained ill defined. Glucose transport into insulin responsive cells is 
accomplished in large parts by insertion of the Na+ independent glucose carriers GLUT1 
(SLC2A1) and GLUT4 (SLC2A4) into the cell membrane (Cushman et al., 1980; James et 
al., 1988; Suzuki et al., 1980). The stimulation of the transporters by insulin requires 
phosphatidylinositide-3-kinase (PI3-kinase) and is abrogated by pharmacological inhibitors 
(Wortmannin and LY294002) or genetic knockout (PI3-kinase dominant-negative mutants) 
of the kinase (Bentley et al., 2003; Cheatham et al., 1994; Haruta et al., 1995; Kotani et al., 
1995; Okada et al., 1994; Perrini et al., 2004). Downstream elements of PI-3-kinase include 
the phosphoinositide dependent kinase PDK-1, which in turn phosphorylates and thus 
activates the serine/threonine kinase Akt/protein kinase B (PKB) (Khan et al., 2002; Lang et 
al., 2001; Virkamaki et al., 1999). The effect of PI3-kinase on GLUT4 trafficking is 
mediated by PKB (Foran et al., 1999; Zhou et al., 2004). PKB is however, at least in some 
cells not required for the PI3-kinase dependent trafficking of GLUT1 (Foran et al., 1999). 
Thus, some other PI3-kinase dependent protein kinase is presumably involved in the 
regulation of GLUT1.  
A further downstream molecule in the PI-3-kinase signalling cascade is the serum- 
and glucocorticoid- inducible kinase SGK1 (Biondi et al., 2001; Kobayashi et al., 1999; 
Park et al., 1999) which has previously been shown to stimulate several transport proteins 
(Lang et al., 2003) including the Na+ coupled glucose transporter SGLT1 (Dieter et al., 
2004). SGK1 was originally cloned as a glucocorticoid sensitive gene from rat mammary 
tumour cells (Firestone et al., 2003; Webster et al., 1993) and later as a human cell volume 
regulated gene (Waldegger et al., 1997). SGK1 is strongly upregulated by mineralocorticoids 
(Bhargava et al., 2001; Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; 
Loffing et al., 2001; Narey-Fejes-Toth et al., 1999; Pearce 2003; Shigaev et al., 2000; Verrey 
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et al., 2003) and participates in the stimulation of the renal epithelial Na+ channel ENaC by 
mineralocorticoids (Chen et al., 1999; Pearce 2003; Shigaev et al., 2000; Verrey et al., 2003; 
Böhmer et al., 2000; Lang et al., 2000; Naray-Fejes-Toth et al., 1999) and insulin (Blazer-
Yost et al., 2003; Blazer-Yost et al., 2004; Tong et al., 2004). 
The present study has been performed to explore whether SGK1 is involved in the link 
between salt intake and glucose tolerance. To this end, experiments were performed in wild 
type animals, in gene targeted mice lacking SGK1 (sgk1-/-) and in their wild type littermates 
(sgk1+/+). Glucose tolerance and peripheral glucose uptake have been determined in animals 
with or without excessive salt intake. The results demonstrate that the effect of excessive salt 
intake on peripheral glucose uptake and alterations of plasma glucose concentration are 
dependent on and mediated by SGK1.  
[The studies referring to these aims, which were displayed in the further sections, have been 
published as an original publication (Boini et al., 2006d)] 
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III.    METHODS 
 
III. 1. Animals: All animal experiments were conducted according to the guidelines of the 
American Physiological Society as well as the German law for the welfare of animals and were 
approved by local authorities. Mice deficient in SGK1 (sgk1-/-) were generated and bred as 
previously described (Wulff et al., 2002; Huang et al., 2004). In brief, a conditional targeting 
vector was generated from a 7-kb fragment encompassing the entire transcribed region on 12 
exons. The neomycin resistance cassette was flanked by two loxP sites and inserted into intron 
11. Exons 4–11, which code for the sgk1 kinase domain, were “floxed” by inserting a third 
loxP site into intron 3. A clone with a recombination between the first and third loxP site (type 
I recombination) was injected into C57BL/6 blastocytes. Male chimeras were bred to C57BL/6 
and 129/SvJ females. Heterozygous SGK1-deficient mice were backcrossed to 129/SvJ wild-
type mice (Charles River, Sulzfeld, Germany) for ten generations and then intercrossed to 
generate homozygous SGK1 knockout mice (sgk1-/-) and their wild type littermates (sgk1+/+). 
In a first study, Male and female SGK1 knockout mice (sgk1-/-) and their wild type littermates 
(sgk1+/+) were fed either a control diet (1310/1314, 4 kcal% fat, 0.25% Na+, 0.36% Cl-, 0.71% 
K+, Altromin, Heidenau, Germany) or a high fat diet (C1000, 45 kcal% fat, 0.25% Na+, 0.36% 
Cl-, 0.71% K+, modified according D12451 from Research Diet, Altromin, Heidenau, 
Germany). Mice were maintained on standard diet until the age of 5 weeks when for half of the 
animals the diet was switched to high fat diet. Within the first 17 weeks mice were allowed 
free access to tap water. After 17 weeks, tap water was replaced by a 1% NaCl solution. In a 
second study, the C57BL/6J strain mice was used. This strain is commonly chosen to induce 
diabetes in mice and exhibits defects in glucose tolerance independent of obesity (Kaku et al., 
1998: Kooptiwut et al., 2002). Male and female SGK1 knockout (sgk1-/-) mice and their wild 
type littermates (sgk1+/+) were fed on a control diet (1314, 0.2% Na+, 0.4% Cl-, 0.7% K+, 
Altromin, Heidenau, Germany) and had free access to tap drinking water. After a control 
period, tap drinking water was replaced by 10 % fructose for 3 weeks. Consequently, the 
control diet was replaced by a high salt diet (1324, 4% NaCl, Altromin, Heidenau, Germany) 
and 10 % fructose was maintained as drinking solution for further 17 days. In another series of 
experiments sgk1+/+ and sgk1-/- mice were kept on a high salt diet for 18 days after a control 
period. In a third study, The 129/SvJ background mice were fed a control diet (1314, Altromin, 
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Heidenau, Germany) and had free access to tap drinking water. After a control period, the 
animals were treated with daily injections of dexamethasone (3 mg/kg b.w., i.p.) for 14 days. 
In a another series of experiments sgk1+/+ and sgk1-/- mice were treated after a control period 
with daily injections of dexamethasone (3 mg/kg, b.w., i.p.) and 1% NaCl in drinking water for 
14 days. In a fourth study, The genetic background of the 129/SvJ four months old male SGK1 
knockout (sgk1-/-) mice and their wild-type littermates (sgk1+/+) were selected. Where 
indicated, female SGK1 knockout (sgk1-/-) mice and their wild-type littermates (sgk1+/+) and 
unrelated (not littermate) wild type male 129/SvJ mice were used. The mice were fed a control 
diet (1310/1314, Altromin, Heidenau, Germany) and were allowed free access to tap water or 
to 1 % NaCl solution. 
 
The following methods were used in all four studies where ever applicable. 
 
III. 2. Glucose tolerance and insulin tolerance test: For determination of glucose tolerance, 
mice were starved overnight and glucose (3 g/kg body weight) was injected intraperitoneally 
(i.p.). Then a drop of blood was drawn from the tail into a test strip of a glucometer 
(Accutrend, Roche, Mannheim, Germany) for measuring the blood glucose levels before and 
15, 30, 45, 60, 75, 90, 120, 150 and 180 minutes after the injection. In another series of 
experiments, long acting insulin (Novo Nordisk, Mainz, Germany) was injected 
intraperitoneally (0.15U/kg, b.w.) and plasma glucose concentrations determined at 0, 15, 
30, 45, 60 and 90 minutes as described above. 
 
III. 3. Blood pressure: Systolic arterial blood pressure was determined by application of 
the tail-cuff method. As reviewed recently (Meneton et al., 2000), the tail cuff approach to 
determine arterial blood pressure requires certain precautions to reduce the stress of the 
animals, including appropriate training of the mice over multiple days, prewarming to an 
ambient temperature of 29°C, measurement in a quiet, semidarkend and clean environment, 
and performance of the measurements by one person and during a defined day time, when 
blood pressure is stable (between 1-3 PM). All these precautions were taken in the present 
study. The tail cuff method has the advantage to be noninvasive and can provide reproducible 
results of systolic blood pressure if those precautions are taken into account (Kurtz et al., 
2005). Blood pressure recording was considered to be successful if the mouse did not move 
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and a clear initial pulse can be seen (Fig. 8). Five tail-cuff measurements were made in a 
session. The blood pressure for the session was accepted when the deviations of the five 
blood pressure readings were less than 5 mm Hg (Fig. 8).  
 
III. 4 Metabolic cages: For evaluation of renal excretion, In a first study, both sgk1-/- and 
sgk1+/+ mice were placed individually in metabolic cages (Tecniplast Hohenpeissenberg, 
Germany) for one week with free access to standard mouse diet or high fat diet both 
containing 0.25% Na+, 0.36% Cl- and 0.71% K+ (Altromin, Heidenau, Germany). The inner 
wall of the metabolic cages was siliconized and urine was collected for 24 hours under 
water-saturated oil every second day when water and food intake were measured (Vallon 
2003). Urinary excretion was determined again in metabolic cages as described above 25 
days after exposure to 1% NaCl in drinking water under both, standard or high fat diet. In a 
second study, For evaluation of renal excretion, both, sgk1-/- and sgk1+/+ mice were placed 
individually in metabolic cages (Techniplast Hohenpeissenberg, Germany) for 24 hour 
urine collection  during a) control diet plus tap water (basal); b) 18 days on high salt diet 
plus tap water (high salt diet); c) 3 weeks on control diet plus 10% fructose in drinking 
water (fructose); d) 17 days on high salt diet plus 10% fructose in drinking water (fructose + 
high salt diet). In a third study, both, sgk1-/- and sgk1+/+ mice were placed individually in 
metabolic cages (Techniplast Hohenpeissenberg, Germany) for 24 hour urine collection 
(Vallon 2003) during contorl diet, control diet plus dexamethasone treatment for 14 days 
and control diet plus dexamethasone treatment and 1% NaCl in drinking water for 14 days. 
 
III. 5 Blood and urinary concentrations: To obtain blood specimen, animals were lightly 
anesthetized with isofluran (Abbott, Wiesbaden, Germany) and about 300 μl of blood was 
withdrawn into heparinized capillaries by puncturing the retro-orbital plexus. For 
determination of non-fasted blood glucose levels and plasma insulin concentrations, blood 
was drawn at 9 am in the morning and centrifuged immediately after the collection. Plasma 
and urinary concentrations of Na+ and K+ were measured by flame photometry (ELEX 
6361, Eppendorf, Germany) and Cl- concentrations were determined by electrometric 
titration (Chloridometer 6610, Eppendorf, Germany). Creatinine concentrations in urine and 
plasma was measured using an enzymatic kit (Demeditec, Kiel, Germany) Plasma 
concentrations of insulin were determined using an enzyme immunoassay kit (Mercodia, 
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Uppsala, Sweden), plasma aldosterone concentrations were measured using a commercial 
RIA kit (Beckman Coulter, Krefeld, Germany). Total cholesterol, triglycerides and free 
fatty acids were analysed using a colorimetric assay (BioVision Research; Sigma; Wako 
Chemicals). Phosphate and Ca2+ concentrations were determined colorimetrically utilizing 
commercial diagnostic kits (Roche Diagnostics, Mannheim, Germany).  
 
III. 6 In vivo glucose uptake: In vivo tissue glucose uptake during a glucose tolerance test 
was determined in male mice that have been starved for 16 hours. 2-deoxy-D-[1,2-3H]-
glucose (2-DOG) was mixed with 20% of regular glucose (10 µCi/mouse, 3g/kg b.w.) and 
injected intraperitoneally. Blood glucose levels were determined to ensure adequate 
injection. After 120 minutes, the mice were killed and 100 mg of tissues were homogenized 
in 1 ml of water. 800 µl of 7% ice-cold perchloric acid was added to 800 µl of homogenate. 
The sample was then cleared by centrifugation and 1 ml of the supernatant was neutralized 
for 30 minutes with 2.2M KHCO3. The precipitate was removed by centrifugation and 500 
µl of the supernatant was used to determine total 3H radioactivity.  
 
III. 7 In vitro glucose uptake: To explore whether SGK1 increases glucose transport, 
HEK-293 cells were seeded on 6-well plates at 0.2 x 106 cells/well and 24 h later, cells were 
transfected with 2 µg constitutively active S422DSGK1, inactive K127NSGK1 or empty vector 
(as a control) by using LipofectamineTM (Invitrogen, Karlsruhe, Germany) according to the 
manufacturer´s instructions. For determination of transport, 3H-deoxy-glucose (2-DOG) was 
used as the glucose analogue. 2-DOG uptake was measured in HEK-293 cells 2 days after 
transfection by incubating the cells at 37 °C for five minutes (linear range of uptake) in 
glucose-free Krebs Ringer HEPES (KRH) buffer containing 0.3 mM of unlabeled 2-DOG, 
0.1 µCi/well [3H] 2-DOG with or without 100 µM phloretin. Uptake was stopped by rapid 
aspiration of uptake solution, and washing four times with ice-cold PBS containing 50 mM 
unlabeled 2-DOG. Thereafter cells were lysed with 10 mM NaOH / 0.1 % Triton X-100 and 
radioactivity was measured with a liquid scintillation counter. Protein concentration was 
determined by the Bradford method. 
 
III. 8 SGK1 protein abundance: In order to explore whether salt loading decreases SGK1 
protein abundance, In one series of experiments, sgk1+/+ mice were divided into 4 groups (5 
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mice per group) and treated separately with 1) Control diet for 3 months 2) Control diet for 
3 months plus 1% NaCl in drinking water for 4 weeks 3) High fat diet for 3 months 4) High 
fat diet for 3 months plus 1% NaCl in drinking water for 4 weeks.  In another series of 
experiments, sgk1+/+ mice were divided into 4 groups (5 mice per group) and treated 
separately with 1) Control diet for 2 weeks  2) Control diet for 2 weeks plus 1% NaCl in 
drinking water for two weeks 3) Control diet for 2 weeks plus DOCA (35mg/kg b.w., s.c) 
treatment for two days 4) Control diet for 2 weeks plus DOCA (35mg/kg b.w., s.c.) and 
spironolactone (50mg/kg b.w., s.c) treatment for two days. Mice were anesthetized with 
ketamine (60mg/kg b.w., i.p.) plus xylazine (10mg/kg b.w., i.p.). Kidneys, skeletal muscle 
and fat tissues were removed and immediately shock frozen in liquid nitrogen. For Western 
blot analysis, the tissues were homogenised by using a homogeniser (Labortechnik, 
Mullheim, Germany). The kidneys were homogenised in lysis buffer containing 50 mM 
Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 50 mM sodium fluoride, 5 
mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1% Triton X-100, 1% sodium 
deoxycholate, 1% sodium dodecyl sulphate and a protease inhibitor cocktail (Complete mini 
EDTA- free, Roche, Mannheim, Germany). The muscle tissues were homogenised in lysis 
buffer containing 50mM Tris-HCl, 50 mM NaF, pH 7, 50 mM β-glycerophosphate, 10 mM 
potassium phosphate, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM sodium vanadate, 
0.1% Tween 20 and a protease inhibitor cocktail tablet (Complete mini EDTA- free, Roche, 
Mannheim, Germany). The fat tissues were homogenised in lysis buffer containing 20 mM 
Tris, pH 7.4, 2 mM EDTA, 137 mM sodium chloride, 1% NP-40, 10% glycerol, 12 mM β-
glycerol phosphate and a protease inhibitor cocktail tablet (Complete mini EDTA- free, 
Roche, Mannheim, Germany). The homogenates were centrifuged at approx. 7000 g, 4 °C 
for 15 min, the supernatant was removed and used for Western blotting. Total proteins were 
measured using the Bradford assay. Total proteins (100µg) were separated by SDS-page 
(10% Tris-Glycine), transferred to nitrocellulose membranes, blocked for overnight in 
blocking buffer (5% fat-free milk in PBS containing 0.1% Tween) at 4°C and incubated 1h 
with a polyclonal anti-SGK1 antibody (diluted 1:1000 in blocking buffer), kindly provided 
by Nicola Perrotti (Catanzaro, Italy), who generated the antibody by immunizing rabbits 
with the peptide EVLHQPYDRTVDW (SGK1 residues 267-280, Zymed laboratories, 
South San Francisco, CA) and subsequently characterized the specificity of the antibody 
(Menniti et al., 2005; Faletti et al., 2002). In single experiment, we tested the antibody in 
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renal tissue from sgk1-/- mice, where the 48 kDa band was missing. However, the antibody 
binds to further proteins, as evidenced from additional bands in the Western blot. After 
incubation with a horseradish peroxidase (HRP)-conjugated anti-rabbit secondary antibody 
(Amersham, Freiburg, Germany) the bands were visualized with enhanced 
chemoluminescence (ECL) according to manufacturer’s instructions. Homogenates were 
also probed with a primary GAPDH (Santa Cruz, Heidelberg, Germany) antibody as a 
loading control. Densitometric analysis of SGK1 was performed by using Quantity One 
software (Bio-Rad Laboratories, California, USA, 1998) and normalized using GAPDH. 
 
III. 9 SGK1 mRNA expression: In one series of experiments, sgk1+/+ wild type mice were 
divided into 4 groups (5 mice per group) and treated separately with 1) control diet; 2) 10% 
fructose for 3 weeks; 3) 4% NaCl diet for 2 weeks; 4) 10% fructose for 3 weeks plus 4% 
NaCl diet for 2 weeks. Mice were anesthetized with ketamine plus xylazine. Kidneys were 
immediately taken out and shock frozen in liquid nitrogen. Tissue RNA was isolated using 
the Qiagen Mini kit and 2 µg of RNA transcribed into cDNA using Reverse Transcriptase 
M-MuLV (Roche Diagnostics GmbH, Roche Applied Science, Mannheim, Germany). An 
aliquot of cDNA, corresponding to the amount of RNA as indicated in each experiment was 
used for quantification of mRNA. Primers used for SGK1 mRNA quantification were sense 
primer: 5’ TGTCTTGGGGCTGTCCTGTATG 3’ and antisense primer: 5’ GCTTCTGCT 
GCTTCCTTCACAC 3’. mRNA was quantified using a light cycler system (Roche 
Diagnostics GmbH, Roche Applied Science, Mannheim, Germany). PCR reactions were 
performed in a final volume of 20 µl containing 2 µl cDNA, 3 mmol/l MgCl2, 0.5 µmol/l of 
each primer, 2 µl cDNA Master Sybr Green I mix (Roche Molecular Biochemicals, 
Mannheim, Germany). The transcript levels of the housekeeping gene GAPDH of each 
sample were taken as reference using a commercial primer kit (Search LC, Heidelberg, 
Germany). Amplification of the target DNA was performed during 35 cycles, each 10 s at 
95°C, 10 s at 68°C and 16 s at 72°C. Melting curve and agarose gel analyses confirmed the 
specificity of amplified products. Results were calculated as a ratio of the target versus 
house keeping gene transcripts. 
 
III. 10 In situ hybridization: For in situ hybridization of SGK1 mRNA, control and 
fructose treated (10% fructose for 3 weeks) mice were killed by carbon dioxide incubation. 
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Kidneys were removed, immediately frozen in –25° C cold isopentane and sliced on a 
freezing microtome at 12 µm thickness. Sections were subsequently mounted on silane 
coated slides (2% 3-aminopropyltriethoxy-silane (Sigma, Taufkirchen, Germany) in 
acetone, dried at 60° C for 30 s and fixed with 4% phosphate buffered paraformaldehyde for 
20 min. After three washes with phosphate buffered saline (PBS, 0.1 M, pH 7.4), slides 
were incubated with TE buffer (100 mM Tris, 50 mM EDTA, pH 8) containing 2 µg/ml 
proteinase K for 10 min at room temperature and rinsed again three times with PBS. In 
order to reduce nonspecific background, slides were acetylated with TEA buffer (0.1 M 
triethanolamine, pH 8.0) containing 0.25% (v/v) acetic anhydride (Sigma) twice for 5 min. 
After pre-hybridization with hybridization buffer (50% formamide (Sigma), 10 % dextrane 
sulfate, 5 mM EDTA, 20 mM Tris pH 8, 10 mM DTT, 1x Denhardt’s solution, 0.05 % 
tRNA, 300 mM NaCl) for 1 h at 62° C, sections were incubated with fresh hybridization 
buffer containing the denatured DIG-labeled sense or antisense probe (200 ng/ml) overnight 
at 63° C. After hybridization, slides were briefly rinsed in 2x SSC at room temperature and 
3 times in 0.1x SSC for 15 min at 63° C. Detection of DIG-labeled RNA probe was 
performed according to the protocol of the DIG nucleic acid detection kit (Roche). The 
tissues were blocked for 30 min with blocking buffer (1% blocking reagent, Roche) in 
maleic acid buffer (0.1 M maleic acid, 0.15 M NaCl, pH 7.5) and then incubated with 
alkaline phosphatase-conjugated antibody solution (anti-DIG antibody, 1:2500 Roche) in 
blocking buffer containing 0.1% Triton® X-100) for 1 h. Following 4 washes with maleic 
acid buffer for 15 min, slides were equilibrated for 5 min in Tris buffer pH 9.5 (0.1 M Tris, 
pH 9.5, 0.1 M NaCl, 50 mM MgCl2). The color development was carried out with freshly 
prepared substrate solution (nitroblue tetrazolium salt (NBT) and 5-bromo-4-chloro-3-
indolyl phosphate (X-phosphate) (Roche) in Tris buffer pH 9.5). After 3 washes with PBS, 
slides were rinsed in distilled water, dried, and coverslipped with Kaiser’s solution (Merck, 
Darmstadt, Germany).  
 
III. 11 In vivo clearance studies: To investigate the role of SGK1 in the antinatriuretic 
action of insulin, male sgk1+/+ and sgk1-/- mice were subjected to renal clearance 
experiments as described before (Huang et al., 2004; Vallon et al., 2005). Briefly, mice 
were anaesthetized using 100 mg/kg i.p. Inactin (Sigma-Aldrich Chemie, Steinheim, 
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Germany) and 100 mg/kg i.m. ketamine (CuraMED Pharma, Karlsruhe, Germany). Animals 
were then placed on a temperature-controlled operating table to keep rectal temperature at 
37°C. Tracheostomy was performed and the right jugular vein was cannulated for 
continuous infusion. Arterial blood pressure was recorded and blood samples were taken via 
a catheter inserted into the left femoral artery. A catheter was placed in the urinary bladder 
for timed urine collection. After the surgery, all mice received a bolus of 0.85% NaCl in an 
amount equal to 5% of body weight. Continuous infusion was maintained at a rate of 
450µl/h/30g body weight and 3H-inulin was added in the infusion for evaluation of whole 
kidney GFR. After stabilization of the animals for 30 min, 30 min timed urine collections 
were performed for determination of basal urinary flow rate, 3H-inulin and sodium 
concentrations. Blood was obtained in the middle of the basal period for measurement of 
blood glucose, 3H-inulin and sodium concentrations. After the basal period, all mice 
received a loading dose of 20mU/kg body weight insulin (Novo Nordisk Pharma, Mainz, 
Germany) i.v. followed by a continuous infusion of 2 mU/kg/min for 60 min. This insulin 
regimen has previously been shown to produce antinatriuresis in rats (Gupta et al., 1992). 
At the onset of the insulin infusion, a 25% glucose infusion was started at the rate of 
3µl/min. Blood glucose was determined at 10-min intervals. The rate of glucose infusion 
was adjusted to maintain the blood glucose concentrations at basal levels. Under those 
conditions, urine and blood were collected as described above. 
 
III. 12 Data analysis and statistics: Data are provided as means ± SEM, n represents the 
number of independent experiments. All data were tested for significance using ANOVA 
and only results with P < 0.05 were considered statistically significant. 
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IV.   RESULTS 
 
IV. 1. Study 1:  Influence of SGK1 on renal function and systolic blood pressure    
                            during high fat diet and high salt diet 
 
IV. 1. 1 Body weight, plasma electrolytes, and intake of food, fluid and electrolytes: Body 
weight was not significantly affected by replacement of tap water with 1% NaCl in sgk1-/- or 
sgk1+/+ mice under standard diet. High fat diet alone caused a similar increase of body weight 
in both genotypes. The additional salt load (1% NaCl) during high fat diet led to a further 
increase of body weight, an effect reaching statistical significance only in sgk1+/+ mice (Table 
2). Replacement of tap water by 1% NaCl increased fluid intake in sgk1-/- mice under both, 
control diet and high fat diet, but in sgk1+/+ mice only under control diet. Fluid intake did not 
significantly increase in sgk1+/+ mice under high fat diet following additional salt load. Thus, 
during high fat diet, fluid intake following replacement of tap water with 1% saline was 
significantly higher in sgk1-/- than in sgk1+/+ mice. High fat diet decreased and 1% NaCl 
increased food intake in both genotypes. Under combined high fat and high salt diet, daily 
intake of Na+ and Cl- was significantly larger in sgk1-/- than in sgk1+/+ mice. Replacement of 
tap water with 1% saline did not significantly affect packed cell volume or plasma Na+ and Cl- 
concentrations. However, high fat diet alone significantly increased plasma Cl- concentrations 
in both genotypes (Table 2). Under combined high fat / high salt intake, plasma K+ 
concentrations were significantly higher in sgk1-/- mice than in sgk1+/+ despite the higher 
plasma aldosterone concentrations in sgk1-/- mice (Table 2).  
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Table 2: Body weight, intake of fluid, food, Na+, Cl- and K+ , packed cell volume, Na+, Cl- 
and K+ concentrations in plasma prior to and following 25 days 1% NaCl intake in 
mice treated with standard diet or high fat diet for 17 weeks. 
   
 
Standard Diet 
Water 1% NaCl 
 
sgk1+/+ sgk1-/- sgk1+/+ sgk1-/-
Body Weight (g) 30.2 ± 1.4 27.7 ± 1.6 31.1 ± 0.9 32.1 ± 2.1 
Fluid Intake (ml/24h) 2.7 ± 0.6 3.0 ± 0.3 5.8 ± 1.5 # 4.4 ± 0.3 # 
Food Intake (g/24h) 3.0 ± 0.3 2.9 ± 0.3 4.6 ± 0.4 # 4.5 ± 0.2 # 
Daily Na+ Intake (µmol/24h) 330 ± 30 318 ± 33 1494 ± 238 # 1231 ± 56 # 
Daily Cl- Intake (µmol/24h) 306 ± 28 294 ± 30 1457 ± 239 # 1195 ± 55 # 
Daily K+ Intake (µmol/24h) 551 ± 51 531 ± 55 842 ± 64 # 822 ± 45 # 
Packed Cell Volume (%) 50 ± 1 48 ± 1 49 ± 1 48 ± 1 
[Na+]plasma (mM) 148 ± 1 148 ± 1 150 ± 3 153 ± 3 
[K+]plasma (mM) 4.6 ± 0.3 4.7 ± 0.3 5.9 ± 0.2 # 5.6 ± 0.4 # 
[Cl-]plasma (mM) 105 ± 3 105 ± 1 115 ± 3 111 ± 2 
 
High Fat Diet 
Water 1% NaCl 
 
sgk1+/+ sgk1-/- sgk1+/+ sgk1-/-
Body Weight (g) 36.5 ± 2.2 § 36.7 ± 2.9 § 43.8 ± 2.3 §# 40.5 ± 4.6 § 
Fluid Intake (ml/24h) 3.3 ± 0.3 3.1 ± 0.4 2.7 ± 0.4 § 4.5 ± 0.6 * 
Food Intake (g/24h) 1.7 ± 0.2 § 2.0 ± 0.2 § 2.8 ± 0.4 #§ 3.4 ± 0.3 #§ 
Daily Na+ Intake (µmol/24h) 190 ± 17 § 220 ± 20 § 767 ± 98 §# 1142 ± 130 #* 
Daily Cl- Intake (µmol/24h) 176 ± 16 § 204 ± 18 § 745 ± 95 §# 1115 ± 129 #*  
Daily K+ Intake (µmol/24h) 317 ± 29 § 367 ± 33 § 501 ± 66 §# 618 ± 46 §# 
Packed Cell Volume (%) 48 ± 3 47 ± 2 47 ± 1 44 ± 3  
[Na+]plasma (mM) 149 ± 1 149 ± 1 145 ± 3 150 ± 3 
[K+]plasma (mM) 4.1 ± 0.2  3.9 ± 0.1 § 4.7 ± 0.2 § 5.5 ± 0.2 #* 
[Cl-]plasma (mM) 126 ± 6 §  120 ± 9 § 115 ± 2 114 ± 2 
   
 
Arithmetic means ± SEM (N=7 mice each group); § p<0.05 vs respective value under 
standard diet, # p<0.05 vs. respective value prior to 1% NaCl; * p<0.05 vs. sgk1+/+. 
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IV. 1. 2 Plasma insulin and aldosterone concentrations: Under standard diet plasma insulin 
concentrations (Fig. 3A) and blood glucose levels (sgk1-/-: 108 ± 10 mg/dl; sgk1+/+: 111 ± 3 
mg/dl, n = 7 each) were similar in SGK1 knockout mice (sgk1-/-) and their wild type littermates 
(sgk1+/+). The replacement of tap water by 1 % NaCl in drinking water did not significantly 
alter plasma insulin levels in either genotype. Plasma aldosterone concentrations were 
significantly higher in sgk1-/- than in sgk1+/+ mice under standard diet and high fat diet alone 
(Fig. 3B). High salt intake significantly decreased plasma aldosterone concentrations to 
similarly low values in both genotypes on control diet. Treatment of the mice for 17 weeks 
with high fat diet did not significantly affect plasma aldosterone concentrations but led to an 
approximately fourfold increase of insulin concentrations (Fig. 3A) and significantly increased 
blood glucose levels (sgk1-/-: 165 ± 16 mg/dl; sgk1+/+: 152 ± 4 mg/dl, n = 7) in both, sgk1-/- and 
sgk1+/+ mice. Subsequent replacement of tap water with 1 % saline in animals treated with high 
fat diet did not affect the plasma insulin concentration (Fig. 3A) or blood glucose levels   
(sgk1-/-: 150 ± 6 mg/dl; sgk1+/+: 152 ± 8 mg/dl, n = 7) but decreased plasma aldosterone 
concentration. Nevertheless, the plasma aldosterone concentration remained significantly 
higher in sgk1-/- mice during high fat plus 1 % NaCl treatment (Fig. 3B). 
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Fig. 3: Plasma insulin (A) and aldosterone (B) concentrations in sgk1-/- and sgk1+/+ 
mice on standard diet (SD) and high fat diet (HFD) prior to and following additional 
1% NaCl in drinking water.  
Arithmetic means ± SEM (n = 7 each group) of plasma insulin (left) and aldosterone 
(right) concentrations in SGK1 knockout mice (sgk1-/-, closed columns) and wild type 
littermates (sgk1+/+, open columns). # p<0.05 vs. respective value under standard diet; § 
p<0.05 vs. respective value prior to 1% NaCl; * p<0.05 vs. sgk1+/+. 
 
 
IV. 1. 3 Hypoglycemic effect of insulin and glucose tolerance in mice during high fat 
diet:  As illustrated in Fig 4, after 14 weeks on high fat diet, the decline of plasma 
glucose concentration following an intraperitoneal injection of insulin (0.15 U/kg body 
weight) was significantly decreased in mice treated with high fat diet fed for 14 weeks 
(Fig. 4). Moreover, the increase of plasma glucose concentration following an 
intraperitoneal glucose load (3 g/kg body weight) was significantly larger in animals 
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treated with high fat diet than in animals under control diet (Fig. 5). Accordingly, high 
fat diet leads to insulin resistance of cellular glucose uptake. The peak plasma glucose 
concentration following a glucose load was significantly higher and the decline of 
plasma glucose concentration following insulin administration was significantly slower 
in sgk1-/- than in sgk1+/+ mice (Figs. 4 and 5). 
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Fig. 4: Plasma glucose concentrations following intraperitoneal injection of insulin in 
sgk1+/+ and sgk1-/- mice. 
Arithmetic means ± SEM (n = 7 each group) of plasma glucose concentrations following 
intraperitoneal injection of insulin (0.15 U/kg, body weight) in SGK1 knockout mice   
(sgk1-/-, closed symbols) and wild type littermates (sgk1+/+, open symbols). Experiments 
were performed on control diet (left panel) and on 14 weeks on high fat diet (right panel).            
* p<0.05 vs. sgk1+/+, # p<0.05 vs. respective value under standard diet. 
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Fig. 5. Plasma glucose concentrations following intraperitoneal glucose injection in 
sgk1+/+ and sgk1-/- mice.  
Arithmetic means ± SEM (n = 7 each group) of plasma glucose concentrations following 
intraperitoneal injection of glucose (3 g/kg body weight) in SGK1 knockout mice (sgk1-/-, 
closed symbols) and wild type littermates (sgk1+/+, open symbols). Experiments were 
performed on control diet (left panel) and on 14 weeks on high fat diet (right panel).            
* p<0.05 vs. sgk1+/+, # p<0.05 vs. respective value under standard diet. 
 
 
IV. 1. 4 SGK1 protein abundance: As illustrated in Fig. 6, high fat diet significantly increased 
the SGK1 protein abundance in kidneys from sgk1+/+  mice. Additional treatment with high salt 
diet led to a decrease of SGK1 protein levels which, however, tended to remain higher than under 
control conditions despite a marked decrease of plasma aldosterone concentration (Fig. 3B). 
Under standard diet replacement of tap water with 1%NaCl significantly suppressed the SGK1 
protein abundance and confirmed the previous observations. 
 47 
SD+1%NaCl      SD         HFD     HFD+1%NaCl
SGK1 (48 kD)
GAPDH (36 kD)
A)
SD SD+1% NaCl HFD HFD+1%NaCl
D
en
si
ty
 S
G
K1
/G
AP
D
H
 (a
rb
ita
ry
 u
ni
ts
)
0
1
2
3
4
5
6
7
8
9
*
*
*
B)
 
Fig. 6: Effect of high fat diet and salt excess on renal SGK1 protein expression 
A. Representative Western blot of renal SGK1 protein abundance under control diet (SD), 
control diet + 1%NaCl (SD+1%NaCl), high fat diet (HFD) and high fat diet + 1%NaCl 
(HFD+1%NaCl) 
B. Arithmetic means ± SEM (n = 5 each group) of renal SGK1 protein abundance in SGK1 
wild type mice under control diet (SD), control diet + 1%NaCl (SD+1%NaCl), high fat diet 
(HFD) and high fat diet +1 %NaCl (HFD+1%NaCl). * p<0.05 vs. control group. 
 
 
IV. 1. 5 Plasma lipid concentrations: No significant differences were observed between the 
genotypes in plasma total triglyceride (Fig. 7B), total cholesterol (Fig. 7A) or free fatty acid 
concentrations (1.4 ± 0.2 mM, n = 6, in sgk1+/+ mice and 1.2 ± 0.2 mM, n = 6, in sgk1-/- mice) 
under control diet. High fat diet increased total plasma triglyceride concentrations about 2.5 
fold in both genotypes (Fig. 7B). Additional 1% NaCl on top of the high fat diet significantly 
reduced total plasma triglyceride concentrations only in sgk1-/- mice. Plasma concentrations of 
free fatty acids were not significantly altered by either high salt diet alone (sgk1-/-: 1.5 ± 0.1 
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mM, n = 6; sgk1+/+:1.2 ± 0.2 mM, n = 6), high fat diet alone (sgk1-/-: 1.5 ± 0.2 mM, n = 7, 
sgk1+/+ 1.4 ± 0.1 mM, n = 7) or combined high fat / high salt treatment (sgk1-/-: 1.6 ± 0.2, n = 6, 
sgk1+/+ 1.5 ± 0.2, n = 6). Total serum cholesterol concentrations were significantly elevated in 
both sgk1-/- and sgk1+/+ mice during high fat and during high fat / high salt treatments (Fig. 
7A). 
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Fig. 7: Plasma total cholesterol (A) and total triglyceride (B) concentrations in sgk1+/+ 
and sgk1-/- mice on standard diet (SD) and on high fat diet (HFD) prior to and following 
additional 1% NaCl in drinking water.  
Arithmetic means ± SEM (n = 7 each group) of plasma total cholesterol (left) and triglyceride 
(right) concentrations in SGK1 knockout mice (sgk1-/-, closed columns) and wild type 
littermates (sgk1+/+, open columns). # p<0.05 vs. respective value under standard diet;         
§ p<0.05 vs. respective value prior to 1% NaCl. 
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IV. 1. 6 Systolic blood pressure: Systolic blood pressure was measured by using tail cuff 
method and the original blood pressure tracing was illustrated in Fig. 8. Under standard diet 
systolic blood pressure was similar in sgk1-/- and sgk1+/+ mice (Fig. 9). Replacement of tap 
water with 1 % NaCl in drinking water did not significantly alter blood pressure in either 
genotype (Fig. 9). Exposure to high fat diet led to a marked and statistically significant 
increase of blood pressure which was similar in both genotypes (Fig. 9). Subsequent exposure 
to 1% NaCl in drinking water at continued high fat diet was followed by a significant increase 
of blood pressure in sgk1+/+ but not in sgk1-/- mice. Accordingly, blood pressure was virtually 
identical in sgk1-/- and sgk1+/+ animals during high fat diet and access to tap water but was 
significantly higher in sgk1+/+ than in sgk1-/- following a 9 or 25 day additional exposure to 1% 
NaCl in drinking water. 
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Fig. 8: Representative original blood pressure tracing measured by tail-cuff method. 
Precautions for tail-cuff pressure measurement were taken in the present study (see method 
section). Blood pressure recording was considered to be successful if the mouse did not 
move and a clear initial pulse (arrow) can be seen. Five tail-cuff recordings were obtained in 
each session. The blood pressure for the session was accepted when the deviations of the 
five blood pressure readings were less than 5 mm Hg. 
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Fig. 9: Systolic blood pressure in sgk1+/+ and sgk1-/- mice on standard diet (SD) or high fat 
diet (HFD) prior to and following additional 1% NaCl in drinking water.  
Arithmetic means ± SEM (n = 7 each group) of systolic blood pressure in SGK1 knockout 
mice (sgk1-/-, black circles) and wild type littermates (sgk1+/+, white circles) before and 9 or 
25 days after addition of 1 % NaCl to drinking water. # p<0.05 vs. respective value prior to 
1% NaCl; * p<0.05 vs. sgk1+/+.  
 
 
IV. 1. 7 Urinary excretion: The increased fluid and NaCl intake following replacement of tap 
water with 1% saline was paralleled by significant increases of urinary flow rate and the 
urinary excretions of NaCl in both genotypes and under both, standard diet and high fat diet 
(Fig.10). However, fluid and NaCl intake (Table 2) and urinary NaCl excretion under 
combined treatment with high fat diet / high salt intake were significantly larger in sgk1-/- than 
in sgk1+/+ mice (Fig 10). Fluid intake and urinary excretion of NaCl were similar in sgk1+/+ and 
in sgk1-/- mice under standard diet plus 1% NaCl (Fig.10).  
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Fig. 10: Urinary excretion of water and electrolytes in sgk1+/+ and sgk1-/- mice on 
standard diet (SD) and high fat diet (HFD) prior to and following additional 1% NaCl in 
drinking water.  
Arithmetic means ± SEM (n = 7 each group) of urinary flow rate, as well as urinary Na+, K+ 
and Cl- excretions in SGK1 knockout mice (sgk1-/-, closed columns) and wild type 
littermates (sgk1+/+, open columns); § p<0.05 vs. respective value prior to 1% NaCl;            
* p<0.05 vs. sgk1+/+.  
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IV. 2. Study 2:  Role of SGK1 in the hypertensive effect of combined treatment with   
                           dietary fructose and salt load 
 
 
IV. 2. 1 Plasma glucose, insulin and aldosterone concentrations: Under control diet blood 
glucose levels and plasma insulin concentrations were similar in SGK1 knockout mice (sgk1-/-) 
and their wild type littermates (sgk1+/+). As reported previously (Wulff et al., 2002), plasma 
aldosterone concentrations were significantly higher in sgk1-/- than in sgk1+/+ mice (Fig. 11). 
As shown in Fig.11, high salt diet alone did not significantly alter blood glucose levels nor 
plasma insulin concentrations whereas plasma aldosterone concentrations were suppressed by 
a high salt diet in both genotypes. As were expected from previous studies, replacement of 
plain tap water with 10% fructose solution as drinking fluid led to a marked increase of blood 
glucose levels and plasma insulin concentrations in both genotypes (Fig. 11). In contrast, 
plasma aldosterone concentrations were not consistently altered by an oral fructose load. The 
additional high salt diet did not significantly affect blood glucose levels or plasma insulin 
concentrations. In both sgk1+/+ and sgk1-/- mice, plasma aldosterone concentrations were 
significantly reduced by an additional high salt diet (Fig. 11). 
 
IV. 2. 2 Packed cell volume, plasma Na+, K+ and Cl- concentrations: Packed cell volume 
and plasma Na+ concentrations were similar in sgk1+/+ and sgk1-/- mice fed on standard diet 
while plasma K+ concentrations in sgk1-/- mice were significantly higher than in sgk1+/+ mice 
(Fig. 12). Following high salt diet, packed cell volume was significantly smaller in sgk1-/- than 
in sgk1+/+ mice. High salt diet significantly increased plasma K+ and Cl- concentrations in both 
genotypes. Fructose load alone did not significantly alter packed cell volume or plasma Na+, 
K+ and Cl- concentrations (Fig. 12). Under combined fructose and high salt diet, plasma K+ and 
Cl- concentrations were modestly elevated in both genotypes. Plasma Na+ concentrations were 
slightly but significantly lower in sgk1-/- than in sgk1+/+ mice treated with combined fructose 
and high salt diet (Fig. 12). 
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Fig. 11: Plasma glucose, insulin and aldosterone concentrations in sgk1+/+ and sgk1-/- mice 
on standard diet (Basal), high salt diet (HSD), fructose load (F) and fructose load + high 
salt diet (F+HSD).  
Arithmetic means ± SEM (N=7 each group) in SGK1 knockout mice (sgk1-/-, closed 
columns) and wild type littermates (sgk1+/+, open columns). # p<0.05 vs. respective value 
under standard diet, § p<0.05 vs. respective value under fructose load, * p<0.05 vs. sgk1+/+. 
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Fig. 12: Packed cell volume, plasma Na+, K+ and Cl- concentrations in sgk1+/+ and sgk1-/- 
mice on standard diet (Basal), high salt diet (HSD), fructose load (F) and fructose load + 
high salt diet (F+HSD). 
Arithmetic means ± SEM (N=7 each group) in SGK1 knockout mice (sgk1-/-, closed 
columns) and wild type littermates (sgk1+/+, open columns). # p<0.05 vs. respective value 
under standard diet, § p<0.05 vs. respective value under fructose load, * p<0.05 vs. sgk1+/+. 
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IV. 2. 3 Fluid intake, urinary flow rate, creatinine clearance and urinary excretion: 
Under control diet, fluid intake, urinary flow rate, creatinine clearance, urinary Na+, K+ and Cl- 
excretions were similar in sgk1-/- and sgk1+/+ mice (Fig. 13). In both sgk1+/+ and sgk1-/- mice, high 
salt diet alone increased fluid intake, urinary flow rate, urinary Na+, K+ and Cl- excretions (Fig. 
13). The addition of 10 % fructose to the drinking water (for 3 weeks) led to a similar increase of 
fluid intake and urinary flow rate in both genotypes, and did not significantly alter creatinine 
clearance, urinary Na+, K+ and Cl- output in neither genotype (Fig. 13). The further addition of 
dietary NaCl (4%) did not significantly alter fluid intake and urine volume but markedly increased 
urinary output of Na+ and Cl- in sgk1+/+ mice, an effect which was enhanced in sgk1-/- mice. Thus 
urinary Na+, Cl- and K+ excretions were higher in sgk1-/- than in sgk1+/+ mice (Na+: 2572 ± 462 vs. 
1428 ± 236; Cl-: 2364 ± 388 vs. 1379 ± 225; K+: 679 ± 115 vs. 370 ± 60 µmol/24h, p<0.05 for 
all) following treatment with combined fructose and high salt treatment. Experiments in 
additional mice treated with combined fructose and high salt diet revealed that food intake 
and thus NaCl and K+ intake were higher in sgk1-/- than in sgk1+/+ mice (3.3±0.4 vs. 2.2±0.2 
g/24h, n=6 per group, p<0.05). Additional high salt diet caused a similar decrease of 
creatinine clearance in sgk1+/+ and sgk1-/- mice on high fructose (Fig. 13). 
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Fig. 13: Fluid intake, urinary flow rate, creatinine clerarance and urinary excretion of 
Na+, K+ and Cl- in sgk1+/+ and sgk1-/- mice on standard diet (Basal), high salt diet (HSD), 
fructose load (F) and fructose load + high salt diet (F+HSD). 
Arithmetic means ± SEM (N=7 each group) in SGK1 knockout mice (sgk1-/-, closed 
columns) and wild type littermates (sgk1+/+, open columns). # p<0.05 vs. respective value 
under standard diet, § p<0.05 vs. respective value under fructose load, * p<0.05 vs. sgk1+/+. 
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IV. 2. 4 Systolic blood pressure: Blood pressure was similar in sgk1+/+ and sgk1-/- mice during 
control diet (98.4 ± 1.9 vs. 98.2 ± 1.1 mmHg) or following administration of fructose alone for 3 
weeks (99.7 ± 0.7 vs. 99.6 ± 0.7 mmHg), but significantly increased only in sgk1+/+ following 
combined treatment with fructose and high salt intake (115 ± 1 vs. 103 ± 0.7 mmHg, p<0.05, Fig. 
14). In contrast, without previous fructose load, high salt diet alone did not significantly affect 
systolic blood pressure in neither genotype (Fig. 14). 
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Fig. 14: Change of systolic blood pressure in sgk1+/+ and sgk1-/- mice on a) standard diet 
(Basal), fructose load for 3 weeks (Fructose) and following 10, 14 and 17 days of fructose 
load + high salt diet  (F+HSD); b) standard diet (Basal) and following 10, 14 and 18 days 
of high salt diet  (HSD). 
Arithmetic means ± SEM (N=6 each group) of systolic blood pressure in SGK1 knockout 
mice (sgk1-/-, black circles) and wild type littermates (sgk1+/+, white circles). # p<0.05 vs. 
respective value under standard diet, § p<0.05 vs. respective value under 3 weeks of 
fructose load , * p<0.05 vs. sgk1+/+. 
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IV. 2. 5 Sgk1 mRNA expression:  As illustrated in Fig. 15, fructose diet significantly increased 
the SGK1 transcript levels in kidneys from sgk1+/+  mice. Additional treatment with high salt diet 
led to a decrease of SGK1 transcript levels which, however, tended to remain higher than under 
control conditions despite a marked decrease of plasma aldosterone concentration (Fig. 11). In 
situ hybridization of SGK1 mRNA identified the glomeruli, cortical tubular structures and 
collecting ducts as the principal sites of SGK1 expression (Fig. 16). Fructose diet again 
caused a significant increase in the SGK1 expression.   
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Fig. 15: Effects of control diet (Control), fructose load (F), 4% NaCl diet (HSD) and 
combined fructose + high salt diet (F+HSD) on renal sgk1 mRNA expression in SGK1 
wild type mice.   
Arithmetic means ± SEM (N=5 each group). * p<0.05 vs. control group 
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Figure 16: In situ hybridization of SGK1 mRNA on kidney cryostat sections of SGK1 
wild type mice with and without fructose load. 
A, B: Overview of SGK1 mRNA expression in the kidneys of untreated (A) and fructose-
treated (B) mice. D, E: Magnification photomicrographs of nephrogenic zones from 
untreated (D) and fructose-treated (E) mice. In the renal cortex of fructose-treated mice 
SGK1 mRNA expression is significantly enhanced. C: Higher magnification of the outer 
cortex of fructose-treated mouse. Glomerula (arrow), tubular structures and collecting ducts 
were strongly stained. F, G: SGK1 expression pattern in the medulla of untreated (F) and 
fructose-treated (G) mice. H: In situ hybridization on cryostat section of kidney with SGK1 
sense probe. Scale bars: A, B = 600 µm; C = 25 µm; D, E = 100 µm; F ,G = 50 µm; H = 
100 µm. 
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IV. 2. 6 In vivo insulin clearance: To further investigate the role of SGK1 in the 
antinatriuretic action of insulin, renal effects of intravenous insulin were determined in 
clearance experiments under anaesthesia. As shown in Table 3, baseline blood pressure, 
glomerular filtration rate (GFR), blood glucose levels, and fractional urinary Na+ excretion were 
similar in sgk1+/+ and sgk1-/- mice. Acute insulin infusion reduced fractional urinary Na+ excretion 
in sgk1+/+ mice, an effect significantly blunted in sgk1-/- mice (Table 3). Thus, fractional urinary 
Na+ excretion was significantly higher in sgk1-/- than in sgk1+/+ mice during the insulin 
administration. Acute intravenous application of insulin did not significantly affect blood 
pressure nor GFR in neither genotype (Table 3). 
MAP (mmHg) GFR (µl/min) Fr-UNaV (%) Blood Glucose (mg/dl)  
basal insulin basal insulin basal insulin basal insulin 
sgk1+/+
 
111 ± 3 110 ± 2 433 ± 36 431 ± 68 7.1 ± 1.3 2.6 ± 0.6 # 121 ± 19 107 ± 13 
sgk1-/- 
 
115 ± 5 114 ± 4 404 ± 88 350 ± 32 9.6 ± 2.5 6.8 ± 1.7 * 103 ± 13 104 ± 15 
62  
 
 
 
 
 
 
 
 
 
 
 
Table 3: Mean arterial pressure, glomerular filtraion rate, fractional urinary sodium excretion and blood glucose levels in the sgk1+/+ 
and sgk1-/- mice before and during insulin clamp (n=6). 
 
 
Arithmetic means ± SEM; MAP: mean arterial pressure; GFR: glomerular filtration rate; Fr-UNaV: fractional urinary sodium excretion; # p<0.05 vs 
respective values under basal, * p<0.05 vs sgk1+/+. 
 
 
 
 
 
 
II. 3. Study 3:  Role of SGK1 in the regulation of electrolyte metabolism and blood   
                         pressure by the glucocorticoid dexamethasone  
 
IV. 3. 1 Plasma glucose, aldosterone and chloride concentrations: As illustrated in Fig. 
17, plasma glucose concentration was similar in SGK1 knockout mice (sgk1-/-) and their wild 
type littermates (sgk1+/+). Dexamethasone led to a significant and similar increase of fasting 
plasma glucose concentration in both genotypes. In neither genotype did additional treatment 
with saline significantly affect fasting plasma glucose concentration. 
 Food intake was not significantly different between genotypes prior to (sgk1+/+ : 4.2 ± 
0.2 g/24 h, n = 9; sgk1-/- : 4.2 ± 0.2 g/24 h, n = 9) and following treatment with 
dexamethasone (sgk1+/+ : 4.1 ± 0.3 g/24 h, n = 12; sgk1-/- : 3.8 ± 0.3 g/24 h, n = 11) and with 
additional treatment with saline (sgk1+/+ : 4.1 ± 0.3 g/24 h, n = 12; sgk1-/- : 3.9 ± 0.3 g/24 h, n 
= 12). Prior to the treatment, plasma aldosterone concentration was significantly higher in 
sgk1-/- than in sgk1+/+ mice. Dexamethasone treatment with or without additional saline load 
significantly decreased the plasma aldosterone concentrations in both genotypes and 
dissipated the difference between the sgk1-/- and sgk1+/+ mice (Fig. 17). Dexamethasone 
tended to decrease packed cell volume in both genotypes, an effect reaching statistical 
significance in sgk1-/- mice (Fig. 17). No significant differences were observed between 
genotypes in packed cell volume prior to and following treatment. Plasma Cl- concentration 
was similar in both genotypes and was not significantly modified by dexamethasone and/or 
saline (Fig. 17). 
 
IV. 3. 2 Plasma Na+, K+, Ca2+ and PO43- concentrations: The plasma concentrations of 
Na+, K+, Ca2+ and PO43- were not significantly different between sgk1+/+ and sgk1-/- mice 
prior to dexamethasone treatment (Fig. 18). Dexamethasone treatment significantly decreased 
the plasma concentrations of  Ca2+ in both genotypes, but the effect on plasma Ca2+ 
concentration was significantly stronger in sgk1-/- than in sgk1+/+ mice. Dexamethasone 
treatment significantly decreased plasma PO43- concentration only in sgk1+/+ mice. Under 
dexamethasone treatment, the plasma Ca2+ concentration was significantly lower and the 
plasma PO43- concentration significantly higher in sgk1-/- than in sgk1+/+ mice (Fig. 18). The 
additional saline treatment dissipated the differences between the genotypes during 
dexamethasone treatment in plasma Ca2+ and PO43- concentration (Fig. 18).  
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 Saline treatment was further followed by a significant increase of plasma potassium 
concentration in sgk1-/- but not in sgk1+/+ mice. As a result, following the combined 
dexamethasone/saline treatment, the plasma potassium concentration was significantly 
higher in sgk1-/- than in sgk1+/+ mice (Fig. 18). 
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Fig. 17: Fasting plasma glucose and aldosterone concentrations, packed cell volume and 
plasma chloride concentration in sgk1+/+ and sgk1-/- mice prior to and following 
dexamethasone treatment without or with additional saline load.  
Arithmetic means ± SEM (N=7 each group) of fasting plasma glucose concentration, plasma 
aldosterone concentration, packed cell volume and plasma chloride concentration in SGK1 
knockout mice (sgk1-/-, closed columns) and wild type littermates (sgk1+/+, open columns) 
prior to and following dexamethasone treatment without or with additional saline load. # 
p<0.05 vs. respective value prior to dexamethasone treatment, § p<0.05 vs. respective 
value prior to saline treatment, * p<0.05 vs. sgk1+/+. 
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Fig. 18: Plasma concentrations of Na+, K+, Ca2+, and PO43- in sgk1+/+ and sgk1-/- mice 
prior to and following dexamethasone treatment without or with additional saline load.  
Arithmetic means ± SEM (N=9-12 each group) of Na+, K+, Ca2+, and PO43- plasma 
concentrations prior to and following dexamethasone treatment (3 mg/kg, b.w., i.p.) for 14 
days in SGK1 knockout mice (sgk1-/-, closed columns) and wild type littermates (sgk1+/+, 
open columns). # p<0.05 vs. respective value prior to dexamethasone treatment, § p<0.05 
vs. respective value prior to saline treatment, * p<0.05 vs. sgk1+/+. 
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IV. 3. 3 Fluid intake, urinary flow rate, creatinine clearance and urinary protein 
excretion: Under control conditions fluid intake, urinary flow rate, creatinine clearance and 
urinary protein excretion were similar in sgk1-/- and sgk1+/+ mice (Fig. 19). The 
administration of dexamethasone did not significantly modify fluid intake, urinary flow 
rate or creatinine clearance in either genotypes. Dexamethasone decreased urinary protein 
excretion, an effect reaching statistical significance in sgk1+/+ mice (Fig.19). Additional 
treatment with saline significantly increased fluid intake, urinary flow rate and urinary protein 
excretion in sgk1+/+ mice. In sgk1-/- mice only the increase of urinary flow rate reached 
statistical significance. At combined treatment with dexamethasone and saline, fluid intake, 
urinary flow rate, creatinine clearance and urinary protein excretion tended to be higher in 
sgk1+/+ mice than in sgk1-/- mice, the differences, however, not reaching statistical 
significance (Fig. 19). 
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Fig. 19: Fluid intake, urinary flow rate, creatinine clearance and urinary protein 
excretion prior to and following dexamethasone treatment without or with additional 
saline load.  
Arithmetic means ± SEM (N=9-12 each group) of fluid intake (ml/24 hours), urinary flow 
rate (ml/24 hours), creatinine clearance (ml/min) and urinary protein excretion (mg/24 hours) 
prior to and following dexamethasone treatment (3 mg/kg, b.w., i.p.) for 14 days in SGK1 
knockout mice (sgk1-/-, closed columns) and wild type littermates (sgk1+/+, open columns). 
# p<0.05 vs. respective value prior to dexamethasone treatment, § p<0.05 vs. respective 
value prior to saline treatment, * p<0.05 vs. sgk1+/+. 
 
IV. 3. 4 Urinary electrolyte excretion: Dexamethasone treatment did not significantly alter 
the absolute urinary excretion of Na+ and K+ in sgk1+/+ and sgk1-/- mice (Fig. 20). 
Dexamethasone treatment tended to decrease, however, the urinary Ca2+ excretion in sgk1+/+ 
mice and increased urinary Ca2+ excretion in sgk1-/- mice. As a result, during dexamethasone 
treatment urinary Ca2+ excretion was significantly higher in sgk1-/- than in sgk1+/+ mice. 
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Dexamethasone treatment tended to decrease urinary PO43- excretion in both genotypes, an 
effect reaching statistical significance in sgk1+/+ mice. The additional treatment with saline 
led to a significant increase of the absolute excretion of Na+ in both genotypes but of Ca2+ 
only in sgk1-/- mice.  
 Similar observations were made on fractional excretions (Fig. 21). Dexamethasone 
treatment significantly increased the fractional urinary Ca2+ excretion in sgk1-/- mice to values 
significantly higher than those in sgk1+/+ mice. Dexamethasone treatment tended to decrease 
the fractional excretions of K+ and PO43- excretion in both genotypes, an effect reaching 
statistical significance only in sgk1+/+ mice for K+ and in sgk1-/- mice for PO43-. Under 
combined treatment with dexamethasone and saline, the fractional PO43-excretion was 
significantly lower than under control conditions in both genotypes (Fig. 21).  
 The absolute urinary excretion of Cl- was not significantly different between 
genotypes prior to (sgk1+/+ : 362 ± 52 µmol/24h, n=9; sgk1-/- : 309 ± 39 µmol/24h, n=9) and 
following treatment with dexamethasone (sgk1+/+ : 270 ± 34 µmol/24h, n=9; sgk1-/- : 294 ± 
40 µmol/24h, n=9) and with additional treatment with saline (sgk1+/+ : 2063 ± 586 µmol/24h, 
n=9; sgk1-/- : 1199 ±  161 µmol/24h, n=9). 
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Fig. 20: Absolute urinary excretion of Na+, K+, Ca2+, and PO43- in sgk1+/+ and sgk1-/- 
mice prior to and following dexamethasone treatment without or with additional saline 
load.  
Arithmetic means ± SEM (N=9-12 each group) of absolute (µmol/24 hours) and fractional 
excretions (% electrolyte clearance/creatinine clearance) of Na+, K+, Ca2+ and PO43- prior to 
and following dexamethasone treatment (3 mg/kg, b.w., i.p.) for 14 days in SGK1 knockout 
mice (sgk1-/-, closed columns) and wild type littermates (sgk1+/+, open columns). # p<0.05 
vs. respective value prior to dexamethasone treatment, § p<0.05 vs. respective value prior 
to saline treatment, * p<0.05 vs. sgk1+/+. 
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Fig. 21: Fractional urinary excretion of Na+, K+, Ca2+, and PO43- in sgk1+/+ and sgk1-/- 
mice prior to and following dexamethasone treatment without or with additional saline 
load.  
Arithmetic means ± SEM (N=9-12 each group) of absolute (µmol/24 hours) and fractional 
excretions (% electrolyte clearance/creatinine clearance) of Na+, K+, Ca2+ and PO43- prior to 
and following dexamethasone treatment (3 mg/kg, b.w., i.p.) for 14 days in SGK1 knockout 
mice (sgk1-/-, closed columns) and wild type littermates (sgk1+/+, open columns). # p<0.05 
vs. respective value prior to dexamethasone treatment, § p<0.05 vs. respective value prior 
to saline treatment, * p<0.05 vs. sgk1+/+. 
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IV. 3. 5 Systolic blood pressure: Systolic blood pressure was similar in untreated sgk1+/+ 
and sgk1-/- mice (Fig. 22). The dexamethasone treatment significantly increased the blood 
pressure in sgk1+/+ mice and tended to increase blood pressure in sgk1-/- mice. During 
dexamethasone treatment, the blood pressure was significantly higher in sgk1+/+ than in   
sgk1-/- mice. Additional saline treatment was followed by a further significant increase of 
blood pressure in both genotypes and dissipated the difference between sgk1-/-  and  sgk1+/+ 
mice (Fig. 22). 
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Fig. 22: Systolic blood pressure in sgk1+/+ and sgk1-/- mice prior to and following 
dexamethasone treatment without or with additional saline load.  
Arithmetic means ± SEM (N=9-12 each group) of systolic blood pressure in SGK1 knockout 
mice (sgk1-/-, closed columns) and wild type littermates (sgk1+/+, open columns) prior to 
and following dexamethasone treatment without or with additional saline load. # p<0.05 vs. 
respective value prior to dexamethasone treatment, § p<0.05 vs. respective value prior to 
saline treatment, * p<0.05 vs. sgk1+/+. 
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IV. 4. Study 4:  Role of SGK1 in salt sensitivity of glucose tolerance and peripheral   
                           glucose uptake 
 
IV. 4. 1 Glucose tolerance tests: Glucose tolerance tests were performed in mice lacking 
SGK1 (sgk1-/-) and in their wild type littermates (sgk1+/+). Prior to the experiments, the animals 
were fed a standard diet and allowed free access to either plain tap water (control) or 1% saline 
solution (high salt). As illustrated in Fig. 23, intraperitoneal (i.p.) injection of glucose (3 g/kg 
b.w.) led to a transient increase of plasma glucose concentration approaching significantly 
higher values in high salt than in control sgk1+/+ mice. The delayed decrease of the plasma 
glucose concentrations after a glucose load points to impaired cellular uptake of glucose in 
saline drinking animals. The effect of saline was observed in both, male (Fig. 23a) and 
female (Fig. 23b) mice.   
 The increase of plasma glucose concentration was significantly larger in tap water 
drinking sgk1-/- mice than in tap water drinking sgk1+/+ mice and similar in tap water drinking 
sgk1-/- mice and saline drinking sgk1+/+ mice (Figs. 23a and 23b). The differences between 
sgk1-/- and sgk1+/+ mice was again apparent in both, male (Fig. 23a) and female (Fig. 23b) 
mice. In sgk1-/- mice the increase of plasma glucose concentration was not significantly 
different between animals drinking tap water and animals drinking saline. Thus, in contrast 
to sgk1+/+ mice, salt excess did not further affect glucose tolerance in sgk1-/- mice. 
 
IV. 4. 2 Insulin tolerance tests: As illustrated in Fig. 24, the decline of plasma glucose 
concentrations following intraperitoneal injection of insulin (0.15U/kg body weight) was 
similarly blunted by salt excess in sgk1+/+ mice. Again, insulin sensitivity of plasma glucose 
concentration was significantly smaller in tap water drinking sgk1-/- mice than in tap water 
drinking sgk1+/+ mice. The salt sensitivity of the insulin induced decrease of plasma glucose 
concentration was significantly smaller in sgk1-/- mice than in sgk1+/+ mice. Those observations 
strongly suggest that SGK1 mediates part of the insulin-induced cellular uptake of glucose and 
substantially contributes to or even accounts for the salt sensitivity of glucose tolerance. 
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Fig. 23: Plasma glucose concentrations following intraperitoneal glucose injection in 
sgk1+/+ and sgk1-/-  male (a) and female (b) mice. 
Arithmetic means ± SEM (N=6 each group) of plasma glucose concentrations following 
intraperitoneal injection of  (3g/kg body weight) glucose in SGK1 knockout mice (sgk1-/-, 
right panel) and in wild type littermates (sgk1+/+, left panel). Experiments were performed 
in mice drinking tap water (open symbols) and in mice drinking 1% NaCl (closed symbols) 
for 14 days. * p<0.05, ** p<0.01 vs. tap water drinking animals, § p<0.05, § § p<0.01 vs. tap 
water drinking sgk1+/+ mice.  
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Fig. 24: Plasma glucose concentrations following intraperitoneal insulin injection in 
sgk1+/+ and sgk1-/-  male (a) and female (b) mice. 
Arithmetic means ± SEM (N=6 each group) of plasma glucose concentrations following 
intraperitoneal injection of (0.15 U/kg body weight) insulin in SGK1 knockout mice (sgk1-/-
, right panel) and wild type littermates (sgk1+/+, left panel). Experiments were performed in 
mice drinking tap water (open symbols) and in mice drinking 1% NaCl (closed symbols) for 
14 days. * p<0.05, ** p<0.01 vs. tap water drinking animals, § p<0.05, §§ p<0.01,               
§§§ p<0.005 vs. tap water drinking sgk1+/+ mice. 
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IV. 4. 3 Glucose tolerance tests during mineralocorticoid excess: As high salt intake 
decreases the plasma concentration of aldosterone, a known stimulator of SGK1 
expression, we explored in sgk1+/+ mice, whether the effect of high salt intake on glucose 
tolerance was due to decreased mineralocorticoid action. Animals were treated with 
subcutaneous injection of the mineralocorticoid DOCA (dissolved in soybean oil, 35 
mg/kg body weight) 4 hours prior to the glucose tolerance test. The DOCA treatment did 
not significantly modify the increase of plasma glucose concentrations in control sgk1+/+ 
mice but significantly blunted the increase of plasma glucose concentrations in saline drinking 
sgk1+/+ mice (Fig. 25). After treatment with DOCA the increase of plasma glucose 
concentrations was similar in saline drinking sgk1+/+mice as in sgk1+/+ mice drinking tap water 
(Fig. 25).    
 The subcutaneous injection of the mineralocorticoid receptor antagonist spironolactone 
(dissolved in soybean oil, 50 mg/kg body weight) did not significantly modify the increase 
of plasma glucose concentrations following glucose injection in control sgk1+/+ mice but 
reversed the effect of DOCA in sgk1+/+ mice on high salt diet. The increase of plasma 
glucose concentration was not significantly different in saline drinking sgk1+/+ mice treated 
with DOCA + spironolactone and saline drinking sgk1+/+ mice without pharmacological 
treatment. The values were, however, significantly higher than the values of untreated tap 
water drinking sgk1+/+ mice (Fig. 25). 
 
IV. 4. 4 In vivo glucose uptake: Further experiments were performed on glucose uptake to 
identify the tissues accounting for the delayed cellular uptake of plasma glucose in salt loaded 
wild type animals or in animals lacking SGK1. To this end radiolabelled 32-DOG was injected 
into the peritoneal cavity and the radioactive tracer was determined in several tissues. As 
illustrated in Fig. 26, glucose uptake in muscle and fat tissue was significantly lower in 
saline drinking sgk1+/+ mice compared to tap water drinking sgk1+/+ mice. Moreover, during 
free access to tap water, glucose uptake into muscle, liver, and fat tissue was significantly 
smaller in sgk1-/- mice than in sgk1+/+ mice. Conversely, glucose uptake into kidney was 
significantly enhanced in sgk1-/- mice, an effect possibly due to enhanced plasma glucose 
concentrations. 
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IV. 4. 5 SGK1 protein abundance: Western blot analysis was performed to determine 
whether the decrease of 2-deoxy-glucose uptake into skeletal muscle and fat tissue was indeed 
paralleled by a decrease of SGK1 protein expression following salt load. As illustrated in Fig. 27, 
SGK1 protein abundance was indeed significantly decreased by high salt intake. Treatment of 
tap water drinking mice with DOCA treatment significantly enhanced the SGK1 protein 
expression, an effect reversed by spironolactone (Fig 27). 
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Fig. 25: Plasma glucose concentrations following intraperitoneal glucose injection in tap 
water drinking and 1% NaCl saline drinking wild type mice with and without prior 
treatment with DOCA  and/or spironolactone . 
Arithmetic means ± SEM (N=6 each group) of plasma glucose concentrations following 
intraperitoneal injection of glucose (3 g/kg body weight) in separately bred SV129 wild 
type mice drinking tap water (open symbols) and or 1% NaCl (closed symbols) for 14 days. 
Animals receiving no drug treatment are labeled with circles, animals receiving DOCA prior 
to the glucose tolerance test are indicated by triangles, animals receiving spironolactone prior 
to the glucose tolerance test are indicated by squares. * p<0.05 vs. tap water drinking 
animals. § p<0.05, §§ p<0.01 vs. DOCA+1% NaCl drinking animals. 
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Fig. 26: 3H-deoxy-glucose uptake into tissues following intraperitoneal glucose injection 
in tap water drinking and saline drinking sgk1+/+ mice as well as in sgk1-/- mice. 
Arithmetic means ± SEM (N=8 each group) of tissue radioactivity following intraperitoneal 
injection of radioactively labelled 2-deoxy-glucose in glucose (3 g/kg body weight). Glucose 
uptake has been determined in wild type mice drinking tap water (open bars), wild type mice 
drinking saline (grey bars) for 14 days and tap water drinking sgk1-/- (black bars). * p<0.05 vs. 
tap water drinking wild type animals. 
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Fig. 27: Effects of control diet, 1% NaCl, DOCA and combined DOCA + spironolactone 
on skeletal muscle (a) and fat tissue (b) SGK1 protein abundance in sgk1+/+ mice  
Effects of control diet (SD), control diet +1% NaCl (SD+1% NaCl), control diet + DOCA 
(DOCA) and control diet + DOCA + spironolactone (DOCA+SPL) on skeletal muscle (left 
panel) and fat tissue (right panel) SGK1 protein abundance in SGK1 wild type mice. 
Arithmetic means ± SEM (N=5 each group). For Western blotting, SGK1/GAPDH band 
intensities from five independent experiments were normalized in each group to the mean 
value of SGK1/GAPDH band intensity of skeletal muscle and fat tissue from control group 
(sgk1+/+ mice).  * p<0.05, *** p<0.005 vs. control group,  §§§ p<0.005 vs. DOCA treated  
mice. 
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IV. 4. 6 In vitro glucose uptake: Those experiments pointed to the ability of SGK1 to 
stimulate cellular glucose uptake. To further test this possibility, constitutively active 
S422DSGK1 or, for comparison, the inactive mutant K127NSGK1 were expressed in HEK293 
cells and 2-DOG uptake determined. As illustrated in Fig. 28, the transfection with active 
S422DSGK1 led to a marked increase of 2-DOG uptake. In contrast, transfection with 
inactive K127NSGK1 rather decreased 2-DOG uptake. In the presence of phloretin 2-DOG 
uptake was markedly reduced and no more sensitive to transfection with S422DSGK1 or 
K127NSGK1. HEK293 cells mainly express GLUT1, which is sensitive to phloretin.  
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Fig. 28: Constitutively active but not inactive SGK1 stimulates 3H-deoxy-glucose 
transport  
HEK-293 cells were transfected with active S422DSGK1, inactive K127NSGK1 or empty 
vector. Labelled 2-DOG uptake was studied 2 days after transfection in the presence and 
absence of phloretin (100 µM). 2-DOG uptake was stimulated by S422DSGK1 (SGK1SD) 
whereas transport remained unaffected upon expression of the inactive K127NSGK1 
(SGK1KN). Arithmetic means ± SEM. (N=4) * p<0.05 vs. transfection with empty vector 
(CONTROL). 
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V.   DISCUSSION 
V. 1.  Study 1:  Influence of SGK1 on renal function and systolic blood pressure during   
                            high fat diet and high salt diet 
 
The present observations confirm the previous study (Wulff et al., 2002) 
demonstrating that under standard diet urinary salt excretion and blood pressure are similar in 
sgk1-/- and sgk1+/+ mice. However, the elevated plasma aldosterone concentrations in sgk1-/- 
mice points to the functional significance of SGK1 dependent regulation of renal salt 
conservation even under those dietary conditions. The enhanced plasma aldosterone 
concentration overrides the lack of SGK1 and allows the maintenance of normal blood 
pressure. The maintenance of blood pressure in sgk1-/- mice is consistent with SGK1 
independent regulation of renal Na+ reabsorption (Wulff et al., 2002).  
The extracellular volume expansion during high salt intake is expected to decrease 
aldosterone release and thus to decrease the expression of SGK1 (Bhargava et al., 2001; 
Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; Loffing et al., 2001; Narey-
Fejes-Toth et al., 1999; Pearce 2003; Shigaev et al., 2000; Verrey et al., 2003). Accordingly, 
salt excess should lower SGK1 expression in wild type mice and thus dissipate the 
differences of SGK1 dependent stimulation of renal tubular Na+ transport between sgk1+/+  
and sgk1-/- mice. 
Under standard diet saline drinking indeed lowers plasma aldosterone concentrations 
and does indeed not lead to differences in blood pressure between sgk1-/- and sgk1+/+ mice. 
Interestingly, plasma aldosterone levels remain elevated in sgk1-/- mice even under high fat 
diet, which is paralleled by increase of blood pressure. Presumably, the increase of blood 
pressure during high fat diet does not translate into enhanced renal perfusion and thus 
remains without effect on renal renin release. Additional saline drinking decreased plasma 
aldosterone concentrations in both sgk1-/- and sgk1+/+ mice. Again, the aldosterone plasma 
levels remained significantly higher in sgk1-/- mice. The difference under this experimental 
condition could be due to increased plasma K+ concentrations, a well known stimulator of 
aldosterone release (Stanton et al., 1982). Plasma K+ concentrations in sgk1-/- mice are at 
least partially enhanced due to impaired renal potassium elimination (Huang et al., 2004; 
Stanton et al., 1982).  
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In contrast to sgk1+/+ mice on a standard diet, sgk1+/+ mice on a high fat diet were 
sensitive to additional salt intake, possibly because the additional salt intake did not lead to 
appropriate downregulation of SGK1 transcript levels. High fat diet markedly increased the 
expression of SGK1 in the kidney. The present study does not address the mechanism 
underlying enhanced renal expression of SGK1. It is noteworthy, though, that high fat diet 
may lead to activation of the peroxisome proliferator-activated receptor gamma (PPARγ) 
(Inoue et al., 2005), which in turn has been shown to enhance SGK1 transcription (Hong et 
al., 2003).  
Moreover, high fat diet leads to increased insulin plasma concentrations. The 
hyperinsulinemia is presumably a result of insulin resistance, as reflected by the decreased 
glucose tolerance and the blunted hypoglycaemic effect of insulin. Irrespective of the diet, the 
glucose tolerance and hypoglycaemic effect of insulin are significantly decreased in sgk1-/- 
mice, pointing to a role of SGK1 in the regulation of cellular glucose uptake. As a matter of 
fact, SGK1 indeed stimulates GLUT1 (Palmada et al., 2006) and glucose uptake into several 
tissues is blunted in sgk1-/- mice (Boini et al., 2006). 
The hyperinsulinemia is expected to stimulate SGK1 and subsequently ENaC 
(Blazer-Yost et al., 1998; Blazer-Yost et al., 1999; Blazer-Yost et al., 2004; Faletti et al., 
2002; Wang et al., 2001). Obesity is associated with peripheral insulin resistance, abnormal 
glucose metabolism and subsequent development of hyperinsulinemia, which in turn favours 
the development of salt sensitive hypertension by insulin dependent stimulation of salt and 
water reabsorption (Catena et al., 2003; de Paula et al., 2004; Et Atat et al., 2004; Hayashida 
et al., 2001; Song et al., 2004). Thus, the hyperinsulinism following high fat diet may 
override the effects of decreasing plasma aldosterone concentrations during high salt diet. 
High fat diet itself increases blood pressure in both genoptypes, an observation pointing to the 
participation of SGK1 independent mechanisms. However, the additional salt load further 
increases blood pressure in sgk1+/+ but not in sgk1-/- mice, an observation disclosing the role 
of SGK1 in hypertension during combined excess of fat and salt. Thus, lack of SGK1 
abrogates salt induced blood pressure increase only under high fat diet. The particular salt 
sensitivity of blood pressure during high fat diet may reflect SGK1 dependent stimulation 
of renal Na+ reabsorption by insulin (Blazer-Yost et al., 1998). 
Interestingly, under high fat diet, the plasma triglyceride levels tend to be lower in 
sgk1-/- mice than in sgk1+/+ mice, a difference reaching statistical significance under 
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additional high salt diet. The presently available evidence does not allow any safe 
statements on underlying mechanisms. It is noteworthy, though, that SGK1 modifies a 
number of transport processes (Lang et al., 2003) and lack of SGK1 may in theory affect 
intestinal absorption of lipids. During high fat diet the additional administration of a salt load 
increased body weight only in sgk1+/+ mice. Under those experimental conditions the sgk1+/+ 
mice may retain more NaCl than the sgk1-/- mice, even though NaCl intake was larger in 
sgk1-/- than in sgk1+/+ mice. As the electrolyte balance could not be fully determined 
throughout the treatment, however, no safe conclusions can be derived in regard to 
differences of extracellular fluid volume.  
 The present observations demonstrate that SGK1 is not only important for the 
prevention of hypotension during salt depletion but may as well contribute to hypertension 
during hyperinsulinism and salt excess. As amplified in the introduction, SGK1 participates 
in the regulation of ENaC and thus renal Na+ excretion by aldosterone, insulin, and IGF-1 
(Blazer-Yost et al., 1998; Blazer-Yost et al., 1999; Wang et al., 2003). While the effect of 
aldosterone is only partially dependent on the presence of SGK1 and effects of aldosterone 
and SGK1 are additive, ADH or insulin do not further stimulate ENaC in cells expressing 
active SGK1 (Arteaga et al., 2005). Thus, activation of ENaC by ADH or insulin fully 
depends on SGK1. The SGK1 dependent stimulation of ENaC is expected to increase 
extracellular fluid volume and thus blood pressure. DOCA treatment increases blood 
pressure similarly in sgk1-/- mice and in sgk1+/+ mice (Vallon et al., 2006), indicating that 
SGK1 is not required for the hypertensive effects of acute mineralocorticoid excess. 
Mineralocorticoids increase salt reabsorption in part by stimulation of ENaC expression, 
an effect presumably not requiring SGK1. On the other hand, SGK1 transcript and protein 
abundance were less in Sprague-Dawley rats and greater in Dahl salt-sensitive rats on 8 % 
versus 0.3 % NaCl diets suggesting that SGK1 may play a role in the pathogenesis of 
hypertension (Farjah et al., 2003). The results of this study are in perfect agreement with 
our observations, that SGK1 plays a particular role in the hypertensive effects of 
hyperinsulinemia.  
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V. 2.  Study 2:  Role of SGK1 in the hypertensive effect of combined treatment with   
                          dietary fructose and salt load 
 
Under both basal conditions and high fructose intake the administration of 4% 
NaCl decreased the plasma aldosterone levels in both sgk1-/- and sgk1+/+ mice and 
abolished the difference between the genotypes. The decrease of plasma aldosterone 
concentrations prevents excessive extracellular volume expansion during high salt intake 
(Bhargava et al., 2001; Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; 
Loffing et al., 2001; Narey-Fejes-Toth et al., 1999; Pearce 2003; Shigaev et al., 2000; Verrey 
et al., 2003). Notably, despite the marked decrease of plasma aldosterone concentration, 
renal SGK1 transcript levels tended to remain higher during combined fructose and high 
salt intake than during control conditions. 
The present observations further confirm the previous observations in sgk1-/- mice on 
129Sv background, that under standard diet, urinary salt excretion and blood pressure are 
similar in sgk1-/- and sgk1+/+ mice (Wulff et al., 2002).  
In contrast to animals of either genotype under control diet, the blood pressure of 
sgk1+/+ mice loaded with fructose is sensitive to additional salt intake. Dietary fructose 
correlates with peripheral insulin resistance, abnormal glucose metabolism and 
hyperinsulinemia, the latter favours the development of salt sensitive hypertension by 
increasing salt and water reabsorption in different nephron segments (Catena et al., 2003; El 
Atat et al., 2004; Hayashida et al., 2001; Song et al., 2004). Indeed, our present 
observations demonstrate that acute intravenous application of insulin at a superphysiological 
dose significantly reduced fractional urinary sodium excretion without affecting blood pressure 
and GFR in sgk1+/+ mice. More importantly, the insulin-induced antinatriuresis was blunted in 
sgk1-/- mice implying a role of SGK1 in insulin-induced renal sodium retention. Presumably 
due to its stimulating effect on the renal epithelial Na+ channel ENaC (Alvarez de la Rosa et 
al., 1999; Böhmer et al., 2000; Chen et al., 1999; Lang et al., 2000; Narey-Fejes-Toth et al., 
1999; wagner et al., 2001) and the Na+/K+ATPase (Henke et al., 2002; Setiawan et al., 
2002; Zecevic et al., 2004) the kinase contributes to the antinatriuretic effect of insulin 
(Bickel et al., 2001; Song et al., 2004; Zhang et al., 2005). Thus, SGK1 may be the primary 
kinase mediating the phosphatidylinositide-3 (PI3)-kinase dependent effects of insulin on 
renal tubular Na+ transport (Blazer-Yost et al., 2003; Blazer-Yost et al., 2004; Tong et al., 
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2004). The upregulation of SGK1 expression by mineralocorticoids (Bhargava et al., 2001; 
Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; Loffing et al., 2001; Narey-
Fejes-Toth et al., 1999; Pearce 2003; Shigaev et al., 2000; Verrey et al., 2003) is expected to 
sensitize the distal nephron for the antinatriuretic effects of insulin. As expressed SGK1 
requires activation through PI-3 kinase and PDK1 (Biondi et al., 2001; Kobayashi and 
Cohen 1999; Park et al., 1999), aldosterone may have smaller effects on renal Na+ transport 
at low insulin levels.  
Notably, fructose alone is not sufficient to elicit SGK1 dependent blood pressure 
increase. It has been shown that increase of arterial blood pressure induced by fructose 
feeding depends on dietary salt intake (Nishimoto et al., 2002). Our data similarly show that 
high fructose intake alone does not significantly alter blood pressure in mice on normal salt 
diet. However, the additional salt load increases blood pressure in sgk1+/+ but not in sgk1-/- 
mice, an observation disclosing the role of SGK1 in hypertension during combined excess 
of dietary fructose and salt. Notably, the different responses in blood pressure occurred 
despite of a greater food intake and thus salt load in sgk1-/- than in sgk1+/+ mice. High fructose 
diet leads to increased insulin plasma concentrations that in turn are expected to stimulate 
SGK1 and subsequently ENaC-mediated Na+ retention in distal nephrons (Blazer-Yost  et 
al., 1998; Blazer-Yost et al., 1999; Blazer-Yost et al., 2004; Wang et al., 2001). A high salt 
diet unmasks the fructose-induced SGK1-dependent renal Na+ retention, and body salt 
balance requires an increase of blood pressure. Our data demonstrate that fructose diet 
significantly increases renal SGK1 transcription levels, and additional high salt diet failed to 
suppress SGK1 mRNA expression to control levels. Besides ENaC, activation of SGK1 could 
increase renal Na+ reabsorption by affecting further transport systems including NHE3 and 
KCNQ1/KCNE1 in proximal tubules or BSC-1 in thick ascending limbs.  Finally, our study 
can not exclude the possibility that SGK1 in addition influences blood pressure through 
further effects on the cardiovascular system.  
The fall in creatinine clearance in response to a high salt diet in mice treated with 
fructose diet may reflect changes in GFR. A decrease in GFR in response to a high salt 
diet, however, would be counterintuitive with regard to salt balance implying a “salt 
paradox”, which has been observed before in rats (Vallon et al., 1997; Vallon et al., 1995) 
and patients (Miller 1997) with type I diabetes mellitus. According to micropuncture 
experiments, diabetes sensitizes proximal tubular reabsorption to dietary salt and thus via 
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respective changes in the luminal signal of the tubuloglomerular feedback elicits the 
paradoxical effect of dietary salt on glomerular filtration rate (Vallon et al., 2002). The 
mechanisms involved are not understood but are independent of renal nerves (Birk et al., 
2003) and angiotensin II receptor activation (Vallon et al., 1995). Further studies are 
required on the effect of salt intake on GFR under conditions of high fructose 
intake/hyperinsulinemia.   
 The present observations demonstrate that SGK1 is not only important for the 
prevention of hypotension during salt depletion but may as well contribute to hypertension 
during salt excess. Along those lines enhanced SGK1 expression has been observed in the salt 
sensitive Dahl rat (Farjah., 2003). In addition, moderately enhanced blood pressure is 
observed in individuals carrying a variant of the SGK1 gene, affecting as many as 5% of 
unselected Caucasians (Busjahn et al., 2002). In the same individuals increased body mass 
index and a shortening of the QT interval (Busjahn et al., 2002; Busjahn and Luft 2003) 
have been observed. The increased body mass index may be partially due to enhanced 
stimulation of the intestinal glucose transporter SGLT1 (Dieter et al., 2004), the 
accelerated cardiac repolarization due to enhanced activation of the cardiac K+ channel 
KCNE1 (Busjahn et al., 2004; Embark et al., 2003). Thus, altered regulation of carriers 
and channels by SGK1 could account for the coincidence of obesity, hypertension and 
altered cardiac action potential (Lang et al., 2003). 
 The present observations provide insight into prerequisites for the SGK1 dependent 
increase of blood pressure and thus may provide a clue to the increased blood pressure in 
those 5 % of the common population carrying the SGK1 gene variant. The observations 
suggest that SGK1 plays a critical role in the hypertensive effect of hyperinsulinism. As a 
gain of function, gene variant of SGK1 could simultaneously increase blood pressure and 
body mass index, SGK1 may indeed be one of the signalling molecules contributing to 
metabolic syndrome or syndrome X, a condition characterized by the coincidence of several 
disorders including hypertension, obesity, insulin resistance and hyperinsulinemia (Roth et 
al., 2003). Metabolic syndrome shares several attributes of Cushing´s syndrome, but does 
not require increased plasma cortisol levels (Bahr et al., 2002). Instead, the disorder may 
be caused by inappropriate activity of downstream signaling elements which could well 
include the serum and glucocorticoid inducible kinase SGK1. 
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V. 3.  Study 3:  Role of SGK1 in the regulation of electrolyte metabolism and blood   
                          pressure by the glucocorticoid dexamethasone  
 
The present observations confirm the mild phenotype of untreated SGK1 knockout 
(sgk1-/-) mice, i.e. the lack of major differences to their wild type littermates (sgk1+/+). In 
previous studies significant differences in renal NaCl excretion were only observed 
following exposure to salt deficient diet (Wulff et al., 2002), and significant differences in 
renal K+ excretion only during acute or chronic K+ loading (Huang et al., 2004). An 
increase in plasma aldosterone appears sufficient to maintain normal renal NaCl 
reabsorption and potassium excretion under basal conditions. 
In untreated sgk1-/- mice the fractional renal Ca2+ excretion is lower, pointing to 
enhanced renal Ca2+ reabsorption (Sandulache et al., 2006). In the present study, the 
absolute and fractional renal Ca2+ excretion was similarly lower in untreated sgk1-/- mice. 
The decreased renal Ca2+ excretion has been attributed to enhanced Ca2+ reabsorption in 
the loop of Henle, paralleling enhanced Na+ reabsorption in this nephron segment. The 
enhanced Na+ reabsorption in the thick ascending limb presumably compensates for the 
impaired SGK1 sensitive Na+ reabsorption in the further distal nephron (Sandulache et al., 
2006). In mice lacking SGK1, compensatory increases in Na+ reabsorption may also occur 
in the proximal tubule (Wulff et al., 2002), a segment in which passive Ca+ reabsorption 
also follows active Na+ reabsorption. This may explain why the renal Ca2+ excretion is 
decreased in untreated sgk1-/- mice despite decreased TRPV5 abundance in the distal 
nephron (Sandulache et al., 2006). The Ca+ channel TRPV5 mediates active Ca2+ 
reabsorption across the luminal membrane of the distal convolution (Hoenderop et al., 
2003). According to coexpression studies in Xenopus oocytes, SGK1 increases the activity 
of TRPV5 at least in part by enhancing the TRPV5 protein abundance in the cell 
membrane (Embark et al., 2004; Palmada et al., 2005). 
The present study revealed that dexamethasone reverses the anticalciuria of the 
sgk1-/- mice and increases renal Ca2+ excretion in sgk1-/- but not in sgk1+/+ mice. Possibly, 
dexamethasone-induced Na+ reabsorption in the aldosterone-sensitive distal nephron is at 
least in part independent of SGK1. Accordingly, dexamethasone treatment would be 
followed by fluid retention, which may suppress Na+ and thus secondarily Ca2+ 
reabsorption in the proximal tubule and/or thick ascending limb. On the other hand, SGK1 
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expression has been observed in thick ascending limbs and may at least in theory 
participate  in the regulation of electrolyte transport in this nephron segment (Alvarez et 
al., 2003; Lang et al., 2000). Moreover, SGK1 has been implicated in the stimulating effect 
of glucocorticoids on Na+/H+-exchanger NHE3 (Yun et al., 2002), which is of primary 
importance for Na+ reabsorption in the proximal tubule (Vallon et al., 2000).  
The dexamethasone-induced renal Ca2+ loss presumably accounts for the excessive 
decline of plasma Ca2+ concentration in sgk1-/- mice. Interestingly, the differences in 
plasma Ca2+ concentration and renal Ca2+ excretion between the genotypes are dissipated 
by additional treatment with saline. Addition of high NaCl diet significantly increased 
renal Ca2+ excretion only in sgk1+/+ mice. High NaCl diet is expected to decrease SGK1 
expression in wild type mice and may thus dissipate the differences between genotypes.  
Glucocorticoids tended to decrease plasma potassium concentration at normal salt 
intake, an effect blunted after saline loading in both genotypes. During salt loading plasma K+ 
concentration is significantly higher in sgk1-/- mice than in sgk1+/+ mice (Huang et al., 
2004). SGK1 has previously been demonstrated to regulate the renal outer medullary K+ 
channel ROMK1 (Yun et al., 2002), and possibly further K+ channels important for renal 
K+ elimination. Beyond that, SGK1 dependent activity of ENaC is expected to depolarize 
the apical cell membrane of principal cells thus favoring K+ secretion. As a result of both, 
renal potassium elimination is impaired in sgk1-/- mice (Huang et al., 2004). The defective 
K+ elimination becomes particularly obvious during combined dexamethasone and salt 
loading. Possibly, the suppressed aldosterone release during combined dexamethasone 
treatment and salt load abrogates the SGK1 independent stimulation of renal K+ excretion 
by aldosterone.  
 Apparently, SGK1 does not contribute significantly to the effect of glucocorticoids 
on fasting plasma glucose concentrations. Glucocorticoids have previously been shown to 
enhance Kv1.5 channel activity in insulin secreting ß cells and thereby suppress insulin 
release, an effect at least partially mediated by SGK1 (Ullrich et al., 2005). Moreover, the 
stimulating effect of dexamethasone on intestinal electrogenic glucose transport is blunted in 
mice lacking functional SGK1 (Grahammer et al., 2006). Those in vivo observations 
parallel the in vitro stimulating effect of SGK1 on the electrogenic Na+-glucose 
cotransporter SGLT1 (Dieter et al., 2004). On the other hand SGK1 upregulates the 
glucose transporter GLUT1 (Palmada et al., 2006), an effect presumably contributing to 
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peripheral glucose uptake (Boini et al., 2006). Thus, glucocorticoid-induced and SGK1-
mediated effects may increase or decrease plasma glucose concentration. Glucocorticoid 
excess significantly increased the peak plasma glucose concentration in both genotypes 
during intraperitoneal glucose load and dissipated the differences between sgk1-/- and  
sgk1+/+ mice. 
 Lack of SGK1 attenuates the hypertensive effects of glucocorticoids, an observation 
expected, if glucocorticoid-induced salt reabsorption along the nephron is mediated in part by 
SGK1. In addition, the effect may reflect a role of SGK1 in the regulation of peripheral 
resistance. Addition of high salt diet to dexamethasone treatment blunted the difference in 
blood pressure between genotypes. This resembles the similar hypertensive response in   
sgk1-/- and sgk1+/+ mice to the mineralocorticoid DOCA plus high salt diet (Vallon et al., 
2005; Vallon et al., 2006). The data indicate that the SGK1-independent upregulation of 
renal salt reabsorption by dexamethasone is apparently sufficient to induce net renal salt 
retention and thus to increase blood pressure. Possibly, in both sgk1-/- and sgk1+/+ mice, 
highly efficient pressure-natriuresis may have prevented any further acute increases in 
blood pressure during combined dexamethasone/high salt diet.  
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V. 4.  Study 4:  Role of SGK1 in salt sensitivity of glucose tolerance and peripheral   
                          glucose uptake 
 
 Excessive salt intake increases blood pressure, an effect paralleled by insulin 
resistance and/or glucose intolerance in salt sensitive subjects (Giner et al., 2001; Ogihara 
et al., 2003). Our present data demonstrate that high salt intake leads to impaired glucose 
tolerance and impaired insulin sensitivity following an intraperitoneal glucose load. More 
importantly, the observations provide a cellular mechanism accounting for this 
pathophysiologically relevant phenomenon. High salt diet decreases SGK1 expression thus 
disrupting SGK1 dependent glucose uptake into several tissues including liver, fat and 
skeletal muscle. The transfection experiments indeed confirm the ability of SGK1 to 
profoundly stimulate glucose uptake.  
 This observation discloses a novel function of SGK1, i.e. the participation in the 
stimulation of cellular glucose uptake by insulin. Accordingly, SGK1 does not only 
integrate the effects of mineralocorticoids and insulin on renal tubular Na+ transport 
(Blazer-Yost et al., 2003; Blazer-Yost et al., 2004; Tong et al., 2004) but similarly affects 
glucose transport.  
 Saline tended to decrease the insulin sensitivity of blood glucose levels in sgk1-/- mice. 
Even though the difference between tap water and saline drinking sgk1-/- mice was not 
statistically significant, in view of the scatter of the data the present experiments do not rule 
out additional SGK1 independent mechanisms leading to insulin resistance during sodium 
excess. Possible candidates include the other SGK or PKB/Akt isoforms. Clearly, the 
contribution of SGK1 to the regulation of cellular glucose uptake is modest and does not 
match the glucose transport stimulating effect of PKB (Foran et al., 1999). Particularly, 
PKB/Akt 2 plays a key role in the stimulating effects of insulin on cellular glucose uptake 
(Bae et al., 2003; jiang et al., 2003; Kohn et al., 1996; McCurdy et al., 2005). Recently, 
PKB/Akt2 has been shown to be required for the upregulation of skeletal muscle glucose 
transport during calorie restriction (McCurdy et al., 2005). However, cellular glucose 
uptake is not disrupted in those mice, pointing to additional kinases serving a similar 
function. One of those kinases could well be SGK1, which may fully account for the 
deranged glucose tolerance during excessive salt intake.  
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 Unlike the expression of PKB, the expression of SGK1 could be up-regulated by a 
variety of hormones, mediators and other regulators (Lang et al., 2001). Most importantly, 
SGK1 is under strong transcriptional control of mineralocorticoids (Bhargava et al., 2001; 
Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; Loffing et al., 2001; Pearce 
2003; Shigaev et al., 2000; Verrey et al., 2003; Naray-Fejes-Toth et al., 1999). Moreover, 
SGK1 expression is markedly upregulated by cerebral ischaemia (Nishida et al., 2004) and 
may contribute to the enhancement of cellular glucose uptake in ischaemic tissues. Along 
those lines the enhanced cerebral SGK1 expression in enriched environment (Lee et al., 2003) 
may serve to adjust glucose uptake to the enhanced demand following stimulation of neuronal 
activity. As suggested in Fig. 26, the tissues with SGK1 sensitive glucose uptake may include 
the brain. Considering the virtually ubiquitous expression of SGK1 (Waldegger et al., 1997) it 
is likely that SGK1 participates in the regulation of nutrient uptake in a variety of further 
tissues.  
 Salt loading has previously been shown to decrease SGK1 expression (Farjah et al., 
2003), an effect at least partially mediated by a decrease of aldosterone concentration 
(Bhargava et al., 2001; Brennan and Fuller 2000; Chen et al., 1999; Djelidi et al., 2001; 
Loffing et al., 2001; Pearce 2003; Shigaev et al., 2000; Verrey et al., 2003; Naray-Fejes-Toth 
et al., 1999). Accordingly, the effect of salt excess on plasma glucose concentrations 
following a glucose load can be reversed by replacing the endogenous mineralocorticoids 
with exogenous DOCA. Moreover, the effect of DOCA is abrogated by the aldosterone 
receptor antagonist spironolactone. However, the increase of plasma glucose concentration 
following a glucose load is not significantly affected by spironolactone in the absence of 
DOCA. Possibly, treatment of tap water drinking mice with spironolactone leads to 
volume depletion, which may lead in turn to mineralocorticoid independent stimulation of 
SGK1 expression, e.g. by increase of angiotensin II. 
 The present observations do not address the mechanisms of SGK1 dependent 
regulation of cellular glucose uptake. Clearly, expression of SGK1 but not of the inactive 
mutant enhances glucose uptake into HEK223 cells, indeed confirming the ability of 
SGK1 to stimulate glucose transport. Most recent in vitro studies revealed the ability of 
SGK1 to enhance phloretin sensitive glucose uptake into adipocytes (Palmada et al., 2006).  
 The stimulating effect of SGK1 on glucose uptake into fat tissue would be expected 
to favour the development of obesity. As a matter of fact a “gain of function” gene variant 
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of SGK1 affecting as many as some 5% of a Caucasian population is associated with 
obesity (Dieter et al., 2004). The obesity may eventually decrease insulin sensitivity 
despite the stimulating effect of SGK1 on glucose uptake. Moreover, the same gene variant 
is associated with increased blood pressure (Busjahn et al., 2002) presumably due to the 
salt retaining property of SGK1 (Wulff et al., 2002). The salt excess would again favour 
insulin resistance. Thus, SGK1 may participate in the pathophysiology of metabolic 
syndrome, a condition characterized by a variety of disorders including hypertension, 
obesity and insulin resistance (Roth et al., 2002). Along those lines, metabolic syndrome 
shares several features with glucocorticoid excess (Bahr et al., 2002) which should 
upregulate SGK1 expression (Firestone et al., 2003). According to the present data, 
upregulation of SGK1 may blunt the peripheral insulin resistance caused by 
glucocorticoids. On the other hand, SGK1 mediates the inhibition of insulin release by 
glucocorticoids (Ullrich et al., 2005). Clearly, additional experiments are required to 
elucidate the role of SGK1 in glucose metabolism.   
 In conclusion, excessive salt intake impairs glucose tolerance and insulin-induced 
glucose uptake. The effect is reversed by application of mineralocorticoids and abrogated 
in SGK1 knockout mice. The observations point to a novel mechanism participating in the 
regulation of cellular glucose transport.  
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